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A  STUDY OF PREVALENCE OF AUTONOMIC DYSFUNCTION IN 
 TYPE- 2 DIABETES MELLITUS  
 
AUTHOR: Prof. Dr.K.Nagarajan, Dr.IVAN A JONES  
  Thanjavur Medical College, Thanjavur- 613004  
BACKGROUND: Autonomic neuropathy is the most neglected aspect of 
diabetes due to difficulties in diagnosis, which requires invasive investigations 
in earlier days, and lack of specific treatment. Most earlier studies have been 
done on  autonomic dysfunction in Type I Diabetes mellitus and there are only a 
few studies on Type II Diabetes mellitus patients. With this in mind, this study 
has been conducted on the prevalence of autonomic dysfunction in Type II 
Diabetes mellitus patients and the association of various factors with this 
disease in the diabetic population  in and around  Thanjavur. 
AIMS & OBJECTIVES: To study the prevalance of autonomic neuropathy in 
previously diagnosed and newly detected patients with Type 2 diabetes mellitus 
in Thanjavur. 
METHODS: 40 type 2 Diabetes mellitus patients and 10 control subjetcs who 
were admitted in Thanjavur medical college were enrolled in the study. Those 
who complied with the inclusion and exclusion criteria were subjected to 
detailed history taking and clinical examination and necessary investigations 
was done and analysis was performed with appropriate statistical methods.  
RESULTS: 90% of patients studied  had  prevalence of diabetic autonomic 
neuropathy. A battery of tests is more accurate in assessing the degree of 
involvement of the autonomic system rather than a single test. Among the tests 
performed, the heart rate response to deep breathing and to postural change 
from lying to standing were found to be the most sensitive in detecting 
prevalence of  autonomic neuropathy 
CONCLUSION: This study revealed a high prevalence of autonomic 
neuropathy in Type2 Diabetes mellitus patients. This was also evident even in 
asymptomatic patients. The squatting test can be used as an early marker of 
dysautonomia. The degree of metabolic control was the factor which had the 
strongest association with severity of autonomic impairment. Thus, this study 
underscores the value of tight metabolic control in the management of Type2 
Diabetes mellitus. 
KEY WORDS: Valsalva manoeuvre, heart rate changes, squatting test. 
 
 
 
 
  
INTRODUCTION 
Diabetes Mellitus, a disease characterized by hyperglycemia caused by  
absolute or relative deficiency of insulin. The persistent hyperglycemia causes a 
diverse functional and morphological alterations which affect almost  all  systems of 
the body  
Before insulin was discovered, diabetic patients died of acute metabolic 
complications like  ketoacidosis, lactic acidosis, or  hyperosmolar nonketotic coma. 
With the invention of insulin and oral hypoglycemic agents many of the late 
complications of diabetes have been discovered  as the patient’s life span increases. 
These include the involvement of the eye, kidney, heart, blood vessels, central, 
peripheral and autonomic nervous systems. These late complications lead to 
considerable morbidity and mortality. 
Although diabetic retinopathy, nephropathy and neuropathy are well known, 
autonomic neuropathy is the most neglected aspect of diabetic late complications due 
to difficulties in diagnosis, which requires invasive investigations in earlier days, and 
lack of specific treatment. 
The earliest reference to diabetic neuropathy was in the last century by 
Eichorst. He postulated  that  persistent tachycardia is due to vagal neuropathy and 
Rundles proposed it as a possible feature of diabetic autonomic neuropathy..Invention 
of simple noninvasive techniques by Ewing DJ.  and the newer investigative technique 
of continuous heart rate monitoring given by Wheeler and Watkins has shown gross 
abnormalities of cardiac autonomic innervation in diabetes. This might lead to 
painless myocardial infarction, altered response to physiological and pathological 
stress and sudden cardiorespiratory arrest leading to death in diabetic patients. The 
incidence and extent of autonomic nervous disease in the population tends to be 
grossly underestimated.  
This could be due to the relatively subtle manifestations, the gradual  onset and 
progression, and that several of these complications occur in those patients who have 
other co-morbid diseases. The tests for autonomic neuropathy are neither well-known 
nor widely practised, despite the fact that simple bedside clinical tests of 
cardiovascular function correlate well with other system involvement by diabetic 
autonomic neuropathy. 
Most earlier studies have been done on  autonomic dysfunction in Type I 
Diabetes mellitus and there are only a few studies on Type II Diabetes mellitus 
patients. Type II DM in  Indians have many  interesting features which includes high  
prevalance ,  strong correlation with genetic factors , with less common obesity and 
earlier onset of diabetes . 
With this in mind, this study has been conducted on the prevalence of 
autonomic dysfunction in Type II Diabetes mellitus patients and the association of 
various factors with this disease in the diabetic population  in and around  Thanjavur. 
 
  
  
 
AIMS OF THE STUDY 
1. To study the prevalance of autonomic neuropathy in previously diagnosed and 
newly detected patients with Type 2 diabetes mellitus in Thanjavur . 
2. To study the prevalance of symptomatic and asymptomatic autonomic 
impairment in Type II Diabetes Mellitus.   
3. To analyse the involvement of parasympathetic and sympathetic system in 
Type 2 Diabetes mellitus patients with autonomic nervous system damage. 
4. To analyse the correlation between cardiovascular responses and age, sex, 
body mass index, duration of the disease and degree of metabolic control.   
5. To find the correlation between autonomic impairment and proteinuria.  
6. To assess the correlation between hypercholesterolemia and autonomic 
neuropathy.  
7. To study the influence of type and regularity of treatment on the severity of 
autonomic neuropathy in Type 2 Diabetes mellitus patients.  
8. To establish the efficacy of the squatting test as an early marker of autonomic 
impairment. 
  
 REVIEW OF LITERATURE 
HISTORY OF DIABETES MELLITUS 
Diabetes was described about 2000 years back. Aretaeus of Cappadocia (About 
150 AD) called the disease and referring to it as Polyuria, gave the name 
"DIABETES"- coming from the Greek words meaning ” To run through ” (Dia - 
Through, Bainein - To go) because he observed that the disease comprised of " a 
liquefaction of flesh and bones into urine " 
In 1674,Thomas Willis discovered ( by tasting it ) the fact that the urine of a 
diabetic person was sweet, " As if infused with honey (MELLITUS)" .This was a 
rediscovery since an ancient Hindu Document by Susrutha in India about 4000 BC 
has described a condition "Madu Meha " the diabatic syndrome consisting of  a 
"Honeyed Urine ". Willis could not name  the chemical nature of the sweet substance. 
In 1776, Mathew Dobson showed  that the sweet substance in diabetic urine is 
‘’sugar’’. This led to a’’ rational dietary approach’’  introduced by Rollo about 29 
years later. Morton (1686) mentioned  the hereditary character of diabetes .In 1859 
Claude Bernard showed the increased glucose content of diabetic blood. In 1869 
Langerhans,  a medical student described the islets in the pancreas which was then 
named after him. In 1874 Kussmaul described  the airhunger of the diabetic patients 
in coma. 
In 1889 Von Mering and Minkovski demonstrated that dogs could get diabetis 
by pancreatectomy. In 12th January 1922 Fredrick Banting and Charles best prepared 
active extract of pancreas in the lab which was capable of lowering blood glucose 
levels. The first patient who received this pancreatic active extract was Leonad 
Thomson, a boy aged 14 years. It took 30 more  years for the development of 
procedures for purifying and modifying insulin. 
In 1936 Hagedorn introduced the first long acting insulin. 
In 1955 Banger and co-worker delineated chemical structure of insulin.  
In 1967 Steiner and Oyer discovered proinsulin molecule.  
In 1977 Insulin gene cloned (Ulrich, Rutter, Goodman, and Co—workers).  
In 1982 With the invention of recombinant technology insulin became the first 
hormone to be  produced by genetic  engineering. 
In modern day medicine most of the complications of diabetes were widely 
investigated. Urinary bladder dysfunction due to diabetic neuropathy was first 
described in 1864 by Marchal Decalvi.7 In 1885 Pary reported a case of a diabetic 
patient with absence of sweating. Buzzard (1890) and Auche (1890) two other 
observers  noted vasomotor and trophic disturbances due to peripheral autonomic 
dysfunction in diabetic patients. 
 Haemoglobin A1c was initially separated from other forms of haemoglobin by 
Huisman and Meyering in 1958 using a chromatographic column. It was described as 
a glycoprotein by Bookchin and Gallop in 1968. Its increase in diabetes was first 
described in 1969 by Samuel Rahbar and coworkers.The reactions during  its 
formation were characterized by Bunn and his co-workers in 1975. The use of 
hemoglobin A1c for monitoring the degree of control of glucose metabolism in 
diabetic patients was proposed in 1976 by Anthony Cerami, Ronald Koenig and 
coworkers. 
 
 
ANATOMY AND PHYSIOLOGY OF AUTONOMIC NERVOUS 
SYSTEM 
The autonomic nervous system is present  throughout the central and 
peripheral nervous system and it consists of two parts, the sympathetic system and 
parasympathetic system. There are afferent and efferent nerve fibers in both systems. 
The peripheral motor portion of the autonomic nervous system consists  of 
preganglionic  and postganglionic nerves.  
SYMPATHETIC SYSTEM 
The sympathetic outflow of central nervous system extends from the  first 
thoracic segment to second lumbar segment (sometimes third lumbar segment).  
 
PREGANGLIONIC FIBERS 
The cell bodies of pre ganglionic nerves are located at intermediolateral grey 
coloumn of spinal cord. The myelinated axons of these neurons leave the spinal cord 
through ventral roots of the first thoracic to third lumbar spinal nerves. 
They pass through white rami communicantes to the paravertebral sympathetic 
ganglion chain, where most of these axons end on the cell bodies of the post 
ganglionic neurons which  it enters. 
Some of these  fibers pass upwards or downwards  in the chain and synapse in 
one of the other ganglion of the chain. Other fibers pass through one of the spinal 
nerves and terminate in the prevertebral ganglia.  
SYMPATHETIC CHAIN 
This lies close to the vertebral column and consist of a  series of sympathetic 
ganglia mostly having  a segmental arrangement. There are 3 cervical, 11  thoracic, 4 
lumbar and 4  sacral ganglia- all paired together with  1 unpaired coccygeal ganglion.  
POST GANGLIONIC FIBRES 
These fibers  mainly arise from ganglion cells either in the sympathetic ganglia 
or in the prevertebral ganglia and pass through the corresponding spinal nerves 
through grey rami supplying various organs. These fibers are unmyelinated C fibers.  
AFFERENT PATHWAY 
The afferent myelinated nerve fibers travel from the viscera through the 
sympathetic ganglion without synapsing and enters the spinal nerves through the  
white rami and reach their cell bodies in the dorsal root ganglia. The central process 
enter the spinal cord and forms the  afferent component of local reflex arc. 
 
PARASYMPATHETIC SYSTEM 
The parasympathetic outflow consists of cranial and sacral outflow. 
EFFERENT OUTFLOW 
The cell bodies of preganglionic parasympathetic nerve fibres are located in 
the brain stem and sacral segments of the spinal cord. The nerve cells which are 
located in the brain stem form parts of nucleus of origin of the following cranial 
nerves. 
 The oculomotor (Edinger westphal nucleus). 
 The facial (Superior salivatory nucleus). 
 The glossopharyngeal (Inferior salivatory nucleus). 
 The vagus (Dorsal nucleus of vagus)  
The axons of these nerve cells emerge from  the brain stem travel in the cranial 
nerves. The sacral connector nerve centers are located in grey matter of the 2nd, 3rd 
and 4th sacral segments of the cord. The myelinated axons leave the spinal cord in the 
anterior nerve roots of the corresponding spinal nerves and form the pelvic splancnic 
nerves. 
The preganglionic fibres synapse in the peripheral ganglia, usually situated 
close to the viscera which  they innervate. These ganglia include the  ciliary, 
pterigopalatine, submandibular and otic ganglia. In certain conditions  the ganglion 
cells are diffusely arranged in nerve plexus such as cardiac plexus, pulmonary plexus 
and in the myenteric plexus of the gastrointestinal tract. The post ganglionic fibres are 
short and innvervate the viscera.  
THE AFFERENT FIBRES 
The afferent fibres mainly travel from the viscera to their cell bodies which are 
located either in the sensory ganglia of the cranial nerves or in the posterior nerve root 
ganglia of the sacrospinal nerves. The principal afferent fibres of the parasympathetic 
system reach the central nervous system through the vagus nerve. 
 
HIGHER CONTROL OF THE AUTONOMIC NERVOUS SYSTEM 
The  higher  nervous centre that  control the lower autonomic  centers  in  the 
brain stem and spinal cord is situated in the hypothalamus. Stimulation of  the  
anterior hypothalamus  influences parasympathetic responses and stimulation of 
posterior part evokes the sympathetic responses. 
 
The lower brainstem centers such as the vasodilator, cardioaccelerator, 
cardiodecelerator centers are situated in the reticular formation of the cerebellum. It is 
believed that  the various levels of control are exerted as a result of the 
interconnection of different regions by the ascending  and descending pathways. 
 
 CENTRAL  NERVOUS  SYSTEM  THAT  INTEGRATE 
CARDIOVASCULAR REFLEXES 
The afferent traffic from the arterial, cardiopulmonary mechanoreceptors and 
chemoreceptors that travel in the glossopharyngeal and vagal nerves has relays in the 
petrosal and nodose ganglia respectively and terminate in the nucleus tractus 
solitarious of the medulla. The cardiac vagal  nonmyelinated afferents seem to project 
to the same part of the nucleus tractus solitarious as the myelinated fibres. This 
nucleus also has input from many other sites, including receptors in the skeletal 
muscles, the trigeminal and vestibular nerves,the hypothalamus and the locus 
cereleus. This array of afferent connections makes the nucleus tractus solitarious an 
important integratory center for reflex control of cardiovascular system. 
Of all the higher centres in the brain, the hypothalamus has an important role in 
arterial blood pressure control. It has multiple connections with the cardiovascular 
neurons in the brain stem and also has connections that  reach preganglionic neurons 
directly. 
RECEPTORS IN THE SKELETAL MUSCLE9  
A strong static (isometric) contraction of the skeletal muscles or a rapid, 
powerful, rhythmic contraction leads to a pronounced increase in arterial pressure and 
heart rate. This increase in perfusion pressure helps to combat the mechanical 
compression of the vessels by the contracting muscle. 
 
When static contraction is performed with one forearm, there is an immediate 
increase in heart rate and arterial pressure which is followed by a continued gradual 
increase in pressure. 
 The rapid increase in the heart rate at the onset of exercise and return to control 
when contraction stops is similar to a " central command" signal from the motor 
cortex to the brain stem cardiovascular centers. In addition to this, there may be a 
rapidly acting excitatory input from group III mechanoreceptors in the contracting 
muscle. Studies in human subjects  suggest that the rapid changes in the heart rate are 
caused  primarily by reduction in the vagal tone. The changes in the arterial pressure 
at the onset of contraction are secondary to a combination of increase in the cardiac 
output and systemic vascular resistance. 
Claude Bernard in 1863 showed that the sympathetic system plays the 
important  role in the continuous adjustment of overall performance of cardiovascular 
system. If the heart is denervated but the sympathetic nerves to the systemic vessels 
are intact, the myocardium becomes supersensitive to the circulatory norepinephrine 
that enters the blood from peripheral nerve endings resulting in increase in heart rate 
and contractility. 
 
 
 
 
 
 
 
 
 
 
Figure 1 - THE AUTONOMIC NERVOUS SYSTEM 
Blue : Parasympathetic  Red : Sympathetic      
 
 
 
 
 
 
 
 
 
Figure 2 Factors involved in the cardiovascular response to the static exercise. 
CS – Carotid Sinus  NE – Norepinephrine SA – Sinoatrial node Ao – Aortic arch Ach – 
Acetylcholine CP –  Cardiopulmonary receptors 
 
 
 
 
 
 
 
 
 
 
 
 
THE ARTERIAL BAROREFLEX 
The baroreceptors of the carotid sinus and aortic arch acts  in such a way as to 
inhibit the vasomotor center tonically. When the pressure in the carotid sinus is 
decreased, the resultant decrease in afferent nerve activity causes an increase in 
arterial pressure. This alteration is caused  from augmented sympathetic activity to the 
heart and blood vessels and diminished vagal activity to the heart. An increase in 
heart rate and cardiac contractility follows together with constriction of resistance 
vessels in muscle, kidney, splanchnic bed, skin and of the splanchnic capacitance 
vessels. The contraction of resistance vessels increases the total systemic vascular 
resistance and resulting in an increased  after load on the heart. The constriction of 
capacitance vessels helps in  maintaining the filling pressure of the heart and hence 
the Stroke volume, thus it maintains the cardiac output. When the pressure within the 
carotid sinus is increased, the reverse is true. 
AUTONOMIC EFFECTS ON VARIOUS ORGANS OF THE BODY 
Circulatory system 
Heart 
Organ Sympathetic  Parasympathetic  
cardiac output  β1, (β2): enhanced M2: depressed 
SA node: heart rate 
(chronotropic) 
β1, (β2) [3]: enhanced M2: depressed 
Atrial cardiac muscle: 
contractility (inotropic) 
β1, (β2)[3]: enhanced M2: depressed 
Ventricular cardiac muscle 
β1, (β2): 
increase in contractility 
(inotropic) 
increase in cardiac muscle 
automaticity [3] 
--- 
at AV node 
β1: 
enhances conduction 
enhances cardiac muscle 
automaticity [3] 
M2: 
depresses conduction  
Atrioventricular block [3] 
 
 
 
BLOOD VESSELS 
Organ Sympathetic  Parasympathetic  
vascular smooth muscle  α1: contracts; β2: relaxes M3: relaxes [3] 
renal artery α1[4]: constricts --- 
larger coronary arteries α1 and α2[5]: constricts [3] --- 
smaller coronary arteries β2:dilates [6] --- 
arteries to viscera α: constricts --- 
arteries to skin α: constricts --- 
arteries to brain α1[7]: constricts [3] --- 
arteries to erectile tissue α1[8]: constricts M3: dilates 
arteries to salivary glands α: constricts M3: dilates 
hepatic artery β2: dilates --- 
arteries to skeletal muscle β2: dilates --- 
Veins  
α1 and α2 [9] : constricts 
β2: dilates 
--- 
 
 
 
 
 
OTHER 
Organ Sympathetic  Parasympathetic  
platelets  α2: aggregates --- 
mast cells - histamine β2: inhibits --- 
RESPIRATORY SYSTEM 
Organ Sympathetic  Parasympathetic  
smooth muscles of bronchioles 
β2: relaxes (major contribution) 
α1: contracts (minor contribution) 
M3: contracts 
 
NERVOUS SYSTEM 
Organ Sympathetic  Parasympathetic  
Pupil dilator muscle  
α1: contraction 
( mydriasis) 
M3: relaxation 
(miosis) 
Ciliary muscle  β2: relaxation M3: contraction 
 
 
 
 
Digestive system 
Organ Sympathetic  
Parasympathetic  
salivary glands:  
β: stimulation of  viscous, 
amylase secretions 
α1: stimulation of  potassium 
cation 
M3: stimulates watery 
secretions 
lacrimal glands  β2: secretion of protein[10] M3: increases 
kidney (renin) β1: [11] secretion --- 
parietal cells  --- M1: Gastric acid secretion 
liver  
α1, β2: glycogenolysis, 
gluconeogenesis 
--- 
adipose cells β1[11], β3: stimulates lipolysis --- 
GI tract (smooth 
muscle) motility 
α1, α2[12], β2: decreases M3, (M1) [3]: increases 
sphincters of GI tract α1 [11], α2 [3], β2: contracts M3: relaxes 
glands of GI tract no effect [3] M3: secretes 
 
 
 
 
ENDOCRINE SYSTEM 
Organ Sympathetic  Parasympathetic  
pancreas 
(islets) 
α2: decreases secretion from beta cells, 
increases secretion from alpha cells 
M3[13] increased secretion from 
alpha and beta cells 
adrenal 
medulla  
N (nicotinic ACh receptor): secretes 
epinephrine and norepinephrine 
--- 
 
URINARY SYSTEM 
Organ Sympathetic  Parasympathetic  
Detrusor urinary muscle of bladder 
wall 
β2: relaxation 
M3: [11] 
contraction 
urethral sphincter (internal) α1: contraction Relaxation 
sphincter  
α1: contraction; β2 
relaxation 
M3:[11] relaxation 
 
 
 
 
 
 
 REPRODUCTIVE SYSTEM 
Organ Sympathetic  Parasympathetic  
uterus  
α1: contracts (pregnant[3]) 
β2: relaxes (non-pregnant[3]) 
--- 
genitalia  α1: contracts (ejaculation) M3: erection 
 
INTEGUMENTARY SYSTEM 
Organ Sympathetic  Parasympathetic  
sweat gland 
secretions 
M: stimulates (major contribution); α1: 
stimulates (minor contribution) 
--- 
erector pili  α1: stimulates --- 
 
 
PHYSIOLOGY10 
Stimulation of sympathetic system leads to widening of palpeberal fissure, 
pupillary dilatation, tachycardia and peripheral vasoconstriction, which inturn causes 
rise in blood pressure, inhibit peristalsis in the alimentary canal , contracts the 
sphincters of alimentary canal and bladder and produces piloerection and sweating. 
Sympathetic excitation causes secretion of adrenaline from the adrenal medulla 
leading to rise in blood pressure. 
 
Stimulation of parasympathetic system causes pupillary constriction, 
bradycardia, vasodilatation, bronchoconstriction, secretion of tears and saliva, 
increased intestinal peristalsis and contraction of bladder and plays a principal part in 
sexual activity. 
Sympathetic nerves are adrenergic and most of the parasympathetic nerves are 
cholinergic. 
PATHOGENESIS OF DIABETIC NEUROPATHY 
Many of the experimental and clinical studies, which have been recently 
reviewed in detail, have provided new thoughts into the pathobiochemical and 
pathophysiological mechanisms which form an important part in the pathogenesis of 
diabetic neuropathy. Five major pathogenetic concepts currently implicated  in the 
pathogenesis are: — 
1. Enhanced flux through the polyol pathway with increased aldose reductase 
activity leading to accumulation of sorbitol, depletion of myoinositol and reduction in 
Na+ - K+ - ATPase activity- Both these biochemical alterations and experimental 
diabetic neuropathy are prevented by administration of aldose reductase inhibitors.11 
2. Reduction in the nerve blood flow and endoneural microvascular 
abnormalities with consecutive ischemia or hypoxia and enhanced generation of 
oxygen free radicals. These abnormalities associated with experimental diabetic 
neuropathy are prevented by different classes of vasodilators, gamma-linoleic acid 
and antioxidant treatment. 
3. Formation of non-enzymatic advanced glycosylation end-products (AGEs) 
in nerve and vessel-wall proteins.13 Aminoguanidine, a competitive inhibitor of AGE 
products normalizes the fall  in nerve blood flow and abnormalities associated with 
experimental diabetic neuropathy.14 
 4. Deprivation of nerve growth factor (NGF) and other neurotropic factors and 
defects in axonal transport. The decrease in nerve growth factor is experimentally 
reversed by establishing normoglycemia.15 
 
5. Immunological processes. A speculative mechanism is based on the theory  
that insulin antibodies may cross-react with nerve growth factor, which is required  
for the growth and survival of sympathetic nerves. Since nerve growth factor and 
insulin share similar antigenic determinants, the action of insulin antibodies may 
cause damage to sympathetic nerves. 16 
Other immunological phenomena consists of increased levels of circulating 
immune complexes and complement breakdown products (CBD) suggesting 
complement activation. In addition, the levels of activated T lymphocytes may be 
higher, proposing that cell mediated immunity may also play a part.17 Also identified 
are antibodies to nervous tissues such as sympathetic ganglia, adrenal medulla and 
vagus nerve. 
Recently Barzilay et al have reported an increased predilection in subjects with 
HLA BR3/4 to develop autonomic dysfunction.18 
Autoantibodies to glutamic acid decarboxylase (GAD) have been seen  in 
small groups of type I diabetic patients with peripheral and/or autonomic neuropathy. 
However recent studies were unable to endorse this first report in patients with 
cardiac autonomic neuropathy.19 
 
 
NEUROPATHOLOGICAL CHANGES IN DIABETIC AUTONOMIC 
NEUROPATHY 
Appenzeller et al described distended ganglion cells also known as "Giant 
sympathetic neurons" and shortened internodal distances in white rami 
communicantes of the paravertebral sympathetic chain.20 
Olsson Y et al described vacuolations of neurons and club-shaped enlargement 
of neural cell processes in autonomic sympathetic ganglia.21 
Low PA et al and Olsson Y et al stated demyelination of preganglonic 
sympathetic fibres. Kristensson et al described similar changes in the Vagus nerve. 
12,21 
 
Subsequently Duchen LW et al established the distended or vacuolated neurons 
and enlarged cell processes in superior cervical and coeliac sympathetic ganglia. They 
also described severe loss of myelinated axons in  sympathetic trunk and vagus nerve 
in patients with Autonomic Neuropathy along with inflammatory cellular infiltration 
by lymphocytes and macrophages circulated in relation to autonomic nerve bundles 
and ganglia.22 
Tamura et al reported a decreased mean myelinated fibre density in the carotid 
sinus nerve, a purely afferent branch of the glossopharyngeal nerve, providing a 
possible neuropathological basis for the baroreceptor dysfunction in diabetic 
patients.23 
Also stated  are nerve fibre thickening, fibre fragmentation and decrease in the 
number of autonomic nerve fibres of the heart muscle in diabetic patients who 
underwent painless myocardial infarction. This led to the theory that a lesion of the 
afferent nerves that conduct pain could be responsible for the lack of pain in these 
patients.24 
Morphological studies of the vasa nervorum in the small nerve fibres from 
diabetic patients gave evidence for autonomic neuropathy of the vasa nervorum that 
could result in defective circulatory autoregulation. 
 
DISTRIBUTION OF AUTONOMIC NEUROPATHY 
By means of Electrophysiological testing, autonomic dysfunction can be seen 
in many diabetics without any other symptoms. Cardiovascular reflex abnormalities 
can be seen shortly after diabetes has been diagnosed and in asymptomatic diabetics 
of longer duration.12 
Cardiovascular involvement is more common than any other system 
involvement. Postural hypotension is a late feature. Diabetics along with symptoms of 
autonomic neuropathy usually have other complications, mainly peripheral 
neuropathy. Both afferent and/or efferent pathways may be affected. 
Cardiac parasympathetic function can be damaged without detectable 
sympathetic damage, but not the contrary.12 Cardiac parasympathetic fibres are 
involved more expansively and earlier than sympathetic nerves. 
 
CLINICAL PRESENTATIONS 
Although destruction to the autonomic nerves involves almost all parts of the 
body, the effect is most apparent clinically in the cardiovascular system. The 
autonomic symptoms are often imprecise and present insidiously, the bulk of diabetics 
with autonomic neuropathy may  go undetected for a considerable time. Over a period 
of years the symptoms may evolve into the elaborate picture of diabetic autonomic 
neuropathy which has been well detected since then accounted by Rundles (1945), 
with a combination of other conditions like postural hypotension, nocturnal diarrhoea, 
gastric problems, bladder symptoms, abnormal sweating, impotence and a failure to 
detect hypoglycemia.2 
 
ASSESSMENT OF CARDIOVASCULAR EFFECTS IN DIABETIC 
AUTONOMIC NEUROPATHY 
Clinical Manifestation 
Three cardiovascular abnormalities that have usually been linked with   
autonomic neuropathy are resting tachycardia, postural hypotension and "painless" or 
"silent" myocardial infarction.8 
1.Heart rate changes: 
A resting tachycardia and a fixed heart rate are typical findings in diabetic 
patients with cardiovascular autonomic neuropathy. 
A large number of studies have described resting heart rates of 90-100 
beats/min and sometimes heart rate increments upto 130 beats/min have been seen in 
combination with diabetic cardiovascular autonomic neuropathy. An average increase 
of 10 beats/min was detected in diabetics when likened with controls. The patients 
with parasympathetic damage have  highest resting heart rates , while those with 
evidence for combined vagal and sympathetic involvement showed lower rates. 
 
A fixed heart rate, defined as unresponsiveness to moderate exercise, stress or 
sleep specifies almost complete cardiac denervation.26 
In one of the series only 1 of 64 patients showed a comparatively fixed heart 
rate during 24 hours of  ambulatory monitoring, but even in this case a small heart 
rate variation is noted. 
This outcome is similar to the situation encountered during pharmacological 
blockade and in the transplanted heart in which marginal heart rate variation can still 
be found perhaps due to intracardiac modulatory mechanisms of parasympathetic and 
sympathetic reinnervation.28 
 
2. Postural Hypotension 
Postural hypotension, documented as the clinical hallmark of autonomic 
neuropathy in diabetic patients, was described decades earlier.. Clinically it is 
characterized by dizziness, blackouts or visual impairment and even syncope 
following change from the lying to the standing posture. Randomly, postural 
hypotension is defined as fall in systolic blood pressure greater than 20 mm hg. 
Venous pooling in the legs leading to  decrease  in cardiac output and arterial 
pressure is the normal result of standing up. Reflex vasoconstriction and cardiac 
acceleration therefore results to restore the blood pressure. In diabetics a failure to 
raise systemic vascular resistance by vasoconstriction, particularly in the splanchnic 
area and in the subcutaneous tissues is mainly responsible for postural hypotension. 
This may be due to damaged sympathetic innervation of resistance vessels along  with 
loss of reflex vasoconstriction.30 
 
 
 
 
3.Silent Myocardial Infarction 
 Occurrence of both symptomatic and asymptomatic coronary artery disease is 
raised in diabetic patients. Cardiac autonomic neuropathy is accountable for an altered 
perception of myocardial ischemia, painless myocardial ischemia and silent infarction. 
 
ASSESSMENT OF CARDIOVASCULAR REFLEX ABNORMALITIES 
IN DIABETICS 
 Before the year of 1970 most tests to observe the autonomic nervous system 
were compound, invasive and often disagreeable. Presently there are many simple and 
non invasive tests to assess autonomic neuropathy. 
These tests are as follows:- 
1. Beat to beat variation 
2. Heart rate response to standing from lying position 
3. Valsalva manoeuvre 
4. Blood pressure response to standing 
5. Blood pressure response to sustained hand grip. 
6. Heart rate response to atropine 
7. Squatting test 
 These tests are based on cardiovascular reflex and are applied to assess 
parasympathetic and sympathetic function.  
1. DEEP BREATHING TEST 
 The beat to beat variation depends on parasympathetic innervation. lt is most 
clear with slow heart rates or during deep breathing. It is decreased by faster heart 
rates, in older subjects, in the presence of cardiac failure and after development of 
intracranial lesion. 
During deep breathing the subject lying quietly breathes deeply at 6 breaths per 
minute, a rate that causes a maximum variation in heart rate and the changes are 
recorded with an ECG machine. The difference between the maximum and minimum 
heart rate gives the difference. 15 beats per minute variation or more is normal and 10 
beats per minute or less is abnormal.  Two modification of this technique have been 
defined. The first measures the "E I ratio", the mean of the longest RR interval during 
expiration to the mean of the shortest R-R interval during inspiration.  The second 
modification is to measure maximum and minimum heart rates from an ECG during a 
period of deep breathing and record the difference. 
 
2. HEART RATE RESPONSE TO STANDING 
 Change of posture from lying to standing produces an assimilated 
cardiovascular response, including changes in heart rate; there is a distinctive and 
rapid increase in heart rate maximal at about the 15th beat after standing with 
subsequent relative bradycardia maximal at about 30th beat. Diabetics with autonomic 
neuropathy shows only a gradual increase or no increase in the heart rate. 
Pharmocologic studies specify that this response is arbitrated by the vagus nerve. This 
reflex response can be simply computed with continuous ECG recording and 
measurement of R-R intervals at beats 15th and 30th after standing to give the 
30th/15th ratio. 
 In normal subjects value is greater than 1.03, whereas in diabetics with 
autonomic neuropathy values are 1.00 or less. The test is objective, simple, 
reproducible and not dependent on age or the resting heart rate. 
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3.VALSALVA  MANOEUVRE 
      The heart rate rises and blood pressure falls during the strain period of valsalva 
manouvre . After release blood pressure promptly rises over shooting its resting value 
and there is slowing of the heart rate . In the event of autonomic damage blood 
pressure  falls during the strain period and there will be slow return to normal after 
release without any overshoot rise in blood pressure and there will be no change in 
heart rate . Previously , intraarterial pressure changes have been standard assessing . 
The heart rate changes give a reliable guide to the associated hemodynamic events .  
    The technique involves the subjects blowing into a mouth piece connected to a manometer 
held at 40mm of HG pressure for 15 sec, while a continuous ECG is recorded. The Valsalva 
ratio is calculated from the ratio of longest R-R interval after the manoeuvre (within 20 beats 
after the manoeuvre) to the shortest R-R interval during the manoeuvre.27 
The Valsalva ratio of 1.21 or greater is normal, 1.11 to 1.20 is borderline and 1.10 or less is 
abnormal.34  
 
4. BLOOD PRESSURE RESPONSE TO STANDING 
 A patient on standing, immediate pooling of blood occurs in the legs with fall 
in blood pressure .This is rapidly adjusted by reflex vasoconstriction and tachycardia. 
A decrease in Systolic blood pressure of 20mm of Hg upon standing is defined as 
abnormal, fall in 11 to 20 mm of Hg is border line and 10 mm of Hg or less is normal. 
The normal ranges and reproductivity of the most commonly used autonomic reflex 
test  has  been  assessed  by several  investigators. 
5.BLOOD PRESSURE RESPONSE TO SUSTAINED HAND GRIP 
Sustained muscular exercise typically causes a heart rate 
dependent rise in Cardiac output, an increase in systemic blood pressure 17 
and no change in peripheral vascular resistance. 
A simple test based on this reflex uses a hand grip dynamometer standardised 
at 30% of the maximum voluntary contraction with measurement of the blood 
pressure during hand grip.37 Patients with autonomic neuropathy have an abnormally 
small diastolic blood pressure rise. A rise in diastolic pressre of 10mm of Hg or lesser 
is abnormal and 11 to 15 of Hg is border line and 16 mm of Hg or greater is normal. 
6. HEART RATE RESPONSE WITH DRUGS 
Drugs that decrease parasympathetic tone like atropine causes a rise in the 
heart rate. Beta blockers decrease the heart rate by reducing the sympathetic tone. In 
diabetics with  autonomic  neuropathy the effects of  these drugs are blunted or 
abolished. 
7.THE SQUATTING TEST 
The effect of squatting in terminating the attack of faintness in cyanotic 
patients was first noted by William Hunt in 1784 . This effect was then explained by 
Sharpey Schafer who noted increase in systemic arterial pressure  followed by 
bradycardia due to reflex vagus effect, in normal individuals assuming squatting 
position from standing . It was also noted when a person stands from a squatting 
posture  there is a decrease in arterial pressure followed by increase in heart rate as a 
result of sympathetic reflex . 
Thus a single test which involves change in position between squatting and 
standing can assess both sympathetic and  parasympathetic activity based on resultant 
cardiac rate .  
The SqTv vagal ratio is the ratio between the base line R-R interval (mean of 
10 beats) during phase-I and longest R-R interval in the first 15 sec of phase –
II(squatting). The SqTs sympathetic ratio is the ratio between base line R-R interval 
and the shortest R-R interval in the first 10 to 20 second of phase – III(standing from 
squatting).  
It has been studied that patients with diabetic autonomic neuropathy have 
values are less than  99%  lower confidence interval for SqTs ratios and greater than  
99% higher confidence interval for  SqTv ratios. 
In patients with mild or no autonomic involvement , the SqTv ratio was 
significantly better than for deep breathing or lying to standing whereas the inverse 
true in case of severe autonomic involvement.  
 
 
OTHER CLINICAL MANIFESTATION  
1. GASTRO INTESTINAL SYSTEM 
Diabetic autonomic neuropathy can involve the whole of the gut and several 
reviews have been published regarding this postulation. 
OESOPHAGUS : 
Symptoms relating to oesophagus are unusual. Infrequently dysphagia and 
heart burn occur in diabetic autonomic neuropathy. Motility disturbances are well 
recognized despite the lack of symptoms. 
Decreased pharyngeal and oesophageal peristalsis after swallowing and 
reduced tone of  the  oesophageal sphincter are noted using manometric techinques by 
Taub et al, , 1979. 
STOMACH : 
 Kassander (1938) established  that  1/5th of the asymptomatic patients had 
gastric distension demonstrated by radiology and he commended the term 
"GASTROPARESIS  DIABETICORUM"  to describe this picture. The symptoms 
have been well  documented by  Taub et al40 and are often  ill-defined with anorexia 
and epigastric fullness after eating. These occur  due  to vagus nerve dysfunction.  
 
GALL BLADDER: 
While enlarged and poorly contracting gall bladder were observed in diabetic 
autonomic neuropathy by Clark et al 1979,8 in a study using ultrasonography.   
Marumo et al (1982) observed impaired gall bladder contraction following 
stimulation. 
SMALL INTESTINE : 
The characteristic episodic nocturnal diarrhoea of autonomic neuropathy  has 
been well documented. The pathophysiology of the condition is not clearly 
understood. Proximal small intestinal motility disturbances involving both 
sympathetic and parasympathetic innervation have been well described in diabetics 
with gastroparesis. Excessive  bacterial growth occurs following intestinal stasis is 
seen in some patients. 
Bile salt malabsorption has been recommended as a likely mechanism42. 
Alpha-2 adrenergic receptors on small intestinal enterocytes have been found to be 
denervated in experimental diabetics recently. It  might be a possible mechanism for 
diabetic diarrhea as they are thought to be responsible for fluid and electrolyte 
absorption  .  
LARGE INTESTINE : 
Constipation is relatively common symptom of autonomic neuropathy.  It is 
probably a result of colonic  atony  due to vagus nerve dysfunction.  
 
 
II.BLADDER DISTURBANCES 
Bladder dysfuntion is one of the common manifestations of autonomic 
neuropathy with an incidence of 26% to 87%. (Firimodt 1980).56 There is gradual 
onset of symptoms and patients are usually asymptomatic for a long time.. Symptoms 
include decreased frequency of micturition, blunted sensation of bladder fullness, 
straining, hesitation, weakness of stream.44 Later overflow incontinence maybe seen. 
These symptoms are ascribed to the damage of sensitive afferent sympathetic and 
parasympathetic fibres supplying  vesical  wall along  with the S2-S4 segmental 
centres in the  spinal cord. 
III.SEXUAL DISTURBANCES 
IMPOTENCE : 
The incidence of impotence in diabetes is almost 50%. The preservation of 
libido is the  striking feature of diabetic impotence . In sexual function in males, 
erection is under controlled by parasympathetic nerves and ejaculation is controlled 
by  sympathetic system.45 
The parasympathetic nerves (Erigentes) plays an improtant role in the 
enlargement of Corpora Cavernosa and Corpora Spongiosa. The impotence in male is 
due to lesion in the parasympthetic nerves of the Corpora Cavernosa and Corpora 
Spongisoa . .lt may also be due to reduced penile blood flow due to Atherosclerosis. 
RETROGRADE EJACULATION : 
Retrograde ejaculation is attributed to sympathetic nerve dysfunction. In 
diabetic patients with sympathetic neuropathy, orgasm occurs without accompanying 
ejaculation, as the semen is forced into the bladder due to relaxed internal vesical 
sphincter. The diagnosis is confirmed by the presence of semen  in the post-coital 
urine.  
IV-SWEATING DISTURBANCES 
Diminished or absent sweating of the feet and in more severe cases the whole 
leg and lower trunk is well documented as a feature of diabetic autonomic 
neuropathy.8 This may  be due to lesion of sympathetic fibres. 
Gustatory sweating noted by Agenaes 1962, later detailed by Watkins (1973)47  
is a further abnormal sweating pattern  seen  in  diabetic autonomic neuropathy. 
Profuse sweating  usually starts on the forehead and  then spreads to the face, scalp 
and neck with in a minute of eating  tasty foods notably cheese. The mechanism is 
uncertain but it has been suggested that aberrant nerve regeneration occurs within the 
territory supplied by the superior cervical ganglion.47 
 
 
V.HYPOGLYCEMIC UNAWARENESS 
Some diabetics with autonomic neuropathy lose their usual adrenergic early 
warning symptoms of hypoglycemia, so called "Hypoglycemia unawareness" and 
may suddenly become unconscious as they develop hypoglycemia.This maybe due to 
inadequate counter  regulatory hormonal responses mediated by both vagal and 
sympathetic nerves.  There may be steeper decrease of blood glucose than usual 
contributing to more rapid loss of consciousness. 
 
VI.PUPILLARY DISORDERS 
Rundles in 19452 noted abnormal pupillary responses caused by autonomic 
damage in diabetics. Both sympathetic dysfunction of dilator pupillae and 
parasympathetic dysfunction of sphincter pupillae are involved. The main clinical 
abnormalities are a reduction in pupil diameter at rest and loss of spontaneous 
oscillation ("HIPPUS") of the Pupil.49 A common and early sign of diabetic 
autonomic neuropathy is failure to dilate quickly in the dark. 
VII PERIPHERAL NEUROPATHY 
The clinical manifestation of somatic neuropathy includes symmetrical 
polyneuropathy, asymmetrical motor diabetic neuropathy and mononeuropathy. 
According to Ewing DJ et al 1981 autonomic neuropathy rarely occurs independent of 
peripheral neuropathy. Other workers have also reported 100% incidence of  
peripheral  neuropathy. 
 
 The most common symptoms are pain and paraesthesia in the feet and hands. 
The signs include loss of tendon reflexes in the lower limbs and "Glove and Stocking" 
impairment of all modalities of sensation. 
The diagnosis of peripheral neuropathy is confirmed by measuring nerve conduction 
velocities in both motor and sensory fibres. 
 
 
ETIOLOGIC CLASSIFICATION OF DIABETES MELLITUS 
I. Type 1 diabetes (β-cell destruction, usually leading to absolute insulin 
deficiency) 
A.  Immune mediated 
B.  Idiopathic 
II. Type 2 diabetes (may range from predominantly insulin resistance with 
relative insulin deficiency to a predominantly secretory defect with 
insulin resistance) 
III. Other specific types 
A. Genetic defects of β-cell function 
B. Genetic defects in insulin action  
C. Diseases of the exocrine pancreas  
1. Pancreatitis   
2. Trauma/pancreatectomy   
3. Neoplasia   
4. Cystic fibrosis   
5. Hemochromatosis   
7. Others   
D. Endocrinopathies  
1. Acromegaly   
2. Cushing’s syndrome   
3. Glucagonoma   
4. Pheochromocytoma   
5. Hyperthyroidism   
6. Somatostatinoma   
7. Aldosteronoma   
8. Others   
E. Drug- or chemical-induced  
1. Vacor   
2. Pentamidine   
3. Nicotinic acid   
4. Glucocorticoids   
5. Thyroid hormone   
6. Diazoxide   
7. β-adrenergic agonists   
8. Thiazides   
9. Dilantin   
10. α-Interferon   
11. Others 
   
F. Uncommon forms of immune-mediated diabetes  
G. Other genetic syndromes sometimes associated with diabetes  
1. Down’s syndrome   
2. Klinefelter’s syndrome   
3. Turner’s syndrome   
4. Wolfram’s syndrome   
5. Friedreich’s ataxia   
6. Huntington’s chorea   
7. Laurence-Moon-Biedl syndrome   
8. Myotonic dystrophy   
9. Porphyria   
10. Prader-Willi syndrome   
11. Others   
IV. Gestational diabetes mellitus (GDM) 
 
Patients with any form of diabetes may require insulin treatment at some stage of the 
disease. Use of insulin does not, of itself, classify the patient. 
Report of the Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus. Diabetes Care 1997;20:1183-97. 
 MATERIALS AND METHODS 
This study comprises of 40 Type 2 diabetes mellitus patients (26 males and 14  
females). 10 healthy volunteers (relatives of patients), 6 males and 4 females were 
studied for age and sex matched control. 
All the patients were admitted in Thanjavur medical college hospital and 
studied as in patients. 
The age range of study population varies from 40 years to 79 years- The 
population studied was divided into four groups according to age groups as follows:- 
1. 40 to 50 years 
2. 51 to 60 years 
3. 61 to 70 years 
4. 71 to 80 years 
The duration of diabetes of the population studied ranges from 0 to 20 years. 
Patients are divided into five groups as follows:— 
1.  <1 year 
2. 1 to 5 years 
3. 6 to 10 years 
4. 11 to 15 years 
5. >15 years 
  
ACCORDING TO FASTING BLOOD GLUCOSE VALUES THE 
SUBJECTS STUDIED WERE DIVIDED INTO THREE GROUPS AS 
FOLLOWS:- 
 
I. good control 
II. Fair control 
III. Poor control 
The duration of diabetes and the type of treatment of the known diabetic subjects 
were taken from the patients file. The diabetic status of the known diabetic patients as 
well as the newly detected diabetic patients was assessed by estimation of fasting 
blood sugar and post prandial blood sugar after 75 gm of oral glucose load. 
The newly detected patients were diagnosed as Type2 Diabetes mellitus according 
t o the criteria laid down by Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus. Diabetes Care 1997; 20:1183-97. 
 
  
Measurement Good  
control 
fair control poor control 
 
HbA1c % 
 
<6.5 
 
6.5-7.5 
 
>7.5 
fasting plasma 
glucose           
(mg/dl) 
 
90-104 
 
105-130 
 
>130 
CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS AND IMPAIRED 
GLUCOSE HOMEOSTASIS 
DIABETES MELLITUS - positive findings from any two of the following tests on 
different days:  
Symptoms of diabetes mellitus* plus casual† plasma glucose concentration >=200 
mg per dL (11.1 mmol per L)  
or 
FPG >=126 mg per dL (7.0 mmol per L)  
or 
2hrPPG >=200 mg per dL (11.1 mmol per L) after a 75-g glucose load  
 
IMPAIRED GLUCOSE HOMEOSTASIS  
Impaired fasting glucose: FPG from 110 to <126 (6.1 to 7.0 mmol per L)  
Impaired glucose tolerance: 2hrPPG from 140 to <200 (7.75 to <11.1 mmol per L)  
NORMAL  
FPG <110 mg per dL (6.1 mmol per L)  
2hrPPG <140 mg per dL (7.75 mmol per L)  
Adapted from Report of the Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus. Diabetes Care 1997; 20:1183-97. 
†--Casual is defined as any time of day without regard to time since last meal. 
*--Symptoms include polyuria, polydipsia or unexplained weight loss. 
FPG=fasting plasma glucose; 2hrPPG=two-hour postprandial glucose. 
 
 
INCLUSION  AND  EXCLUSION CRITERIA 
1. Newly detected as well as known diabetic patients were included in the 
study. 
2. Patients with coronary artery disease, cardiac arrythmia , valvular heart 
disease and cardiac failure were excluded from the study. 
3. Patients with previous history of myocardial infarction were excluded. 
4. Known hypertensive patients and patients with airway disease were 
excluded. 
5. Patients with central and peripheral nervous system disease except those 
associated with Type 2 DM were excluded from the study. 
6. Patients who are on beta blockers, ACE inhibitors, calcium channel 
blockers, digitalis and other drugs likely to affect the autonomic 
function were excluded. 
7. Patients with any other chronic illness were also excluded. 
By means of structured questionnaire patients were asked questions aimed at 
assessing the presence of the following symptoms of autonomic neuropathy. 
1. Dizziness/vertigo/postural instability on standing. 
2. Regional hypohidrosis/hyperhidrosis. 
3. Dysphagia/vomiting/post-prandial gastric fullness/ nocturnal diarrohea 
4.  Diminished bladder sensation/decreased frequency of micturition  
    hesitation and weakness of urinary stream / urinary incontinence.  
5. Impotence in males. 
6. Tingling and numbness of extremities. 
 Symptoms were scored as present or absent.  If there was any doubt regarding 
any symptom it was scored as absent. Symptomatic autonomic neuropathy was 
considered to be present if one or more symptoms are present.  
 
 
ASSESMENT OF METABOLIC CONTROL 
Recent trends favour the use of glycosylated hemoglobin as the most sensitive 
indicator of metabolic control. In an analysis of 4000 patients Chandalia et al reported 
that glycosylated hemoglobin provides a different interpretation as compared to blood 
glucose in about half of the diabetes. He suggested that such a difference is more 
marked in Type1 diabetes mellitus patients who tend to have greater fluctuation in 
insulin and blood glucose compared to those with Type2 diabetes mellitus. He also 
claims that estimation of hemoglobin A1c can nullify the effects of patients 
consciously changing their diet on the day prior to the test. In this study we have 
specifically ensured that patients continue with their normal diet at the time of the test 
.Seshiah et al opined that for the same reason (viz. lesser  fluctuation  in insulin and 
blood  glucose in Type 2 patients fasting blood glucose can be used as a  relatively 
accurate indicator of overall metabolic control- Recently, an  Italian study by Veglio 
et al conducted on 221 Type 2 patients hemoglobin A1c was highly significantly 
correlated with the fasting blood glucose value (p=<0.0001).. The extensively 
researched marker, currently in use for the long term monitoring of the glycemic 
status among diabetics, is the Glycated hemoglobin test. Whereas all the other tests 
measuring glucose indicates only the immediate Glycemic status , Glycated 
hemoglobin (GHb) is the only test that gives the measure of mean blood glucose 
(MBG) “round the clock” for the last 2-3 months.  The approximate mapping between 
HbA1c values and estimated average blood glucose measurements is given by the 
following equation:60 
eAG(mg/dl) = 28.7 × A1C − 46.7 
eAG(mmol/l) = 1.59 × A1C − 2.59 
Data in parentheses are 95% CIs. 
Control of fasting hyperglycemia is necessary but usually insufficient for 
achieving HbA1c goals <7%. Control of postprandial hyperglycemia is essential for 
achieving recommended HbA1c goals.62 
Three levels of glycemic control, namely, good (HbA1c ≤7%)/ mpg 170mg%, 
fair (HbA1c >7–9%)/mpg170-240mg%, and poor (HbA1c >9%) /mpg>240mg%have 
been recognised. 
Of interest, in patients with diabetes, the prandial glucose level is more 
strongly correlated with HbA1c than is the fasting glucose level.61 
 
 
 
 
 
 
 
 CORRELATION BETWEEN HBA1C LEVEL AND MEAN PLASMA 
GLUCOSE LEVELS ON MULTIPLE TESTING OVER 2–3 MONTHS 
                 
 
 
 
 
 
 
RELATIONSHIP OF MEAN BLOOD GLUCOSE AND 
GLYCOSYLATED HAEMOGLOBIN. 
 
 
 
 
 
 
 
 
 
HbA1C 
(%) 
Mean plasma glucose 
mg/dl mmol/l 
6 135 7.5 
7 170 9.5 
8 205 11.5 
9 240 13.5 
10 275 15.5 
11 310 17.5 
12 345 19.5 
METHODS : 
CARDIOVASCULAR TESTS 
Seven cardiovascular autonomic tests were done to assess both sympathetic 
and parasympathetic function. Four tests evaluating parasympathetic, two tests 
evaluating sympathetic and one test evaluating both parasympathetic and sympathetic 
function. These tests are:  
1. Deep breathing test  
2. Heart rate response to standing 
3. Heart rate response to valsalva manouvre 
4. Heart rate response to intravenous atropine  
5. Blood pressure response to standing  
6. Blood pressure response to sustained hand grip 
7. Squatting test 
All ECGs were recorded in BPL Cardiart 108T/MK-vl  ECG machine 
1. DEEP BREATHING TEST 
To assess heart rate response to deep breathing at six cycles per minute, the 
patient sits quietly and is connected to ECG machine. The patient is instructed to 
breathe deeply and evenly at six breaths per minute (Five seconds in and five seconds 
out). The heart rate was recorded in lead II simultaneously with ECG machine. 
The maximum and the minimum heart rates during each 10 sec breathing cycle 
are measured and the mean of the differences for three successive breathing cycles 
gives the heart rate variation. A variation score of 9 or less is abnormal. Another way 
to express heart rate changes is the ratio of the longest R-R interval during expiration 
to shortest R-R interval during inspiration, the E:I ratio.33 
In this study the heart rate change is expressed as EI ratio. It is calculated as 
follows:— 
             𝐸𝐼 𝑟𝑎𝑡𝑖𝑜 =  
𝑀𝑒𝑎𝑛 𝑜𝑓 𝑙𝑜𝑛𝑔𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑒𝑥𝑝𝑖𝑟𝑎𝑡𝑖𝑜𝑛 
𝑆ℎ𝑜𝑟𝑡𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑖𝑛𝑠𝑝𝑖𝑟𝑎𝑡𝑖𝑜𝑛 
 
2. 30th /15th RATIO TEST. 
To assess heart rate response to standing up from lying position. The subject is 
asked to lie quietly on a couch and then to stand up unassisted, tracing are recorded in 
lead II with ECG machine continuously during standing up time for more than 30 
beats. The 30/15th ratio is calculated as follows:- 
30
15
𝑅𝑎𝑡𝑖𝑜 =
𝑇ℎ𝑒 𝑙𝑜𝑛𝑔𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑎𝑟𝑜𝑢𝑛𝑑 30𝑡ℎ 𝑏𝑒𝑎𝑡
𝑇ℎ𝑒 𝑠ℎ𝑜𝑟𝑡𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑎𝑟𝑜𝑢𝑛𝑑 15𝑡ℎ 𝑏𝑒𝑎𝑡
 
 
3.VALSALVA MANOUEVRE. 
To assess heart rate response to Valsalva manouevre. The technique involves the 
subjects to blow into a mouth piece connected to a manometer up to 40 mm of Hg pressure 
for 15 sec and asked to stop blowing. A continuous ECG is recorded in standard lead II 
during the st raining period  and immediately after the release of pressure for 30 sec. The 
valsalva ratio is calculated as follows- 
𝑉𝑎𝑙𝑠𝑎𝑙𝑣𝑎 𝑅𝑎𝑡𝑖𝑜  =
𝑙𝑜𝑛𝑔𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑖𝑚𝑚𝑒𝑑𝑖𝑎𝑡𝑒𝑙𝑦 
𝑎𝑓𝑡𝑒𝑟 𝑡ℎ𝑒 𝑚𝑎𝑛𝑜𝑒𝑢𝑣𝑟𝑒 (𝑤𝑖𝑡ℎ 𝑖𝑛 𝑎𝑏𝑜𝑢𝑡 20 𝑏𝑒𝑎𝑡𝑠)
𝑠ℎ𝑜𝑟𝑡𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑡ℎ𝑒 𝑚𝑎𝑛𝑜𝑒𝑢𝑣𝑟𝑒
 
 
 
4.HEART RATE RESPONSE TO INTRAVENOUS ATROPINE 
This test was carried out by injecting 1.8mg of atropine sulphate by slow IV route. 
The ECG is recorded in standard lead II during rest before injection when the subject 
is lying quietly and three minutes after IV atropine. 
The difference in heart rate is expressed as a ratio and is calculated as follows 
(Gulati,1980)54 :  
𝐻𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒 𝑅𝑒𝑠𝑝𝑜𝑛𝑠𝑒 𝑡𝑜 𝐴𝑡𝑟𝑜𝑝𝑖𝑛𝑒  
=
𝐿𝑜𝑛𝑔𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑟𝑒𝑠𝑡
𝑠ℎ𝑜𝑟𝑡𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑎𝑓𝑡𝑒𝑟 𝐼𝑣 𝑎𝑡𝑟𝑜𝑝𝑖𝑛𝑒
 
 
5. POSTURAL BLOOD PRESSURE TEST 
This is a simple test to measure the integrity of sympathetic pathway. Blood  
pressure was measured  with  the  patient  in  supine  position  and  after  standing  for  
2 min. 
A decrease in systolic blood pressure of 20mm of Hg or more and / or a fall in 
diastolic pressure grater than 10mm Hg upon standing is abnormal.8 
6. BLOOD PRESSURE RESPONSE TO SUSTAINED HAND GRIP 
This test was performed in this study as follows;- 
The subjects were asked to maintain handgrip at 30% of maximum voluntary 
contraction upto 5min. Using aneroid manometer, the blood pressure was measured 
each minute.  
The difference between the diastolic blood pressure just before the release of 
handgrip and before starting is taken as the measure of response. 
 
7. SQUATTING TEST 
In this study standard squatting test was performed while a continuous ECG was 
recorded in lead II. Also subjects were instructed to refrain from smoking and 
drinking coffee on the test day. Each subject stood still for 3min (Phase I) and then 
squatted 1min. (Phase II). Lastly, each  patient  stood up during inspiratory phase and 
remained in the standing position for 1min (Phase III)  The squatting  induced heart 
rate changes was expressed by SqT vagal ratio (SqTv) and SqT sympathetic ratio 
(SqTs) which are calculated as follows. 
𝑆𝑞𝑇𝑣 =  
𝐵𝑎𝑠𝑒 𝑙𝑖𝑛𝑒 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑝ℎ𝑎𝑠𝑒 𝐼 
(𝑚𝑒𝑎𝑛 𝑜𝑓 10 𝑏𝑒𝑎𝑡𝑠 𝑗𝑢𝑠𝑡 𝑏𝑒𝑓𝑜𝑟𝑒 𝑠𝑞𝑢𝑎𝑡𝑡𝑖𝑛𝑔)
𝐿𝑜𝑛𝑔𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑖𝑟𝑠𝑡 15 sec 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒 𝐼𝐼
 
         𝑆𝑞𝑇𝑠 =  
 
𝐵𝑎𝑠𝑒 𝑙𝑖𝑛𝑒 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑑𝑢𝑟𝑖𝑛𝑔 𝑝ℎ𝑎𝑠𝑒 𝐼
𝑠ℎ𝑜𝑟𝑡𝑒𝑠𝑡 𝑅 − 𝑅 𝑖𝑛𝑡𝑒𝑟𝑣𝑎𝑙 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑖𝑟𝑠𝑡 10 𝑡𝑜 20 sec 𝑜𝑓 𝑝ℎ𝑎𝑠𝑒 𝐼𝐼
 
The results are interpreted with reference to normal ranges for SqT ratio's in 
normal subjects of 20 - 74 years of age (Marfella R et al, 1974)38 as shown in this 
table. Normal ranges for SqT ratios in normal subjects 20—74 years of age. 
Age 
(years) 
n 
SqTs  ratio     (CI) SqTv ratio (CI) 
        
Lower 95% Lower 99% Higher 95% Higher 99% 
20-24 56 1 .55 1.54 0.50 0.61 
25-29 53 1.47 1.46 0.61 0.62 
30-34 67 1 .43 1.42 0.63 0.64 
35-39 42 1.36 1.34 0,66 0.67 
40-44 54 1.32 1.31 0.71 0.72 
45-49 40 1.29 1,28 0.73 0.74  
50-54 48 1 .26 1.24 0.77 0.78 
55-59 60 1 .20 1.19 0.82 0.83 
60-64 53 1 .15 1.14 0.86 0.87 
65-69 45 1.10 1.09 0.89 0.90 
70-74 40 1 .07 1.06 0.92 0.93 
 
Abnormal values are less than the lower 99% CI (Confidence Interval) for 
SqTs ratios and greater than the Higher 99% CI for SqTv ratios. 
 
INTERPRETATION OF TEST RESULTS  
 
Name of the test  Normal  Borderline  Abnormal  
Valsalva ratio ≥ 1.21 1.11 – 1.20 ≤  1.10 
EI ratio* ≥ 1.21 1.11 – 1.20 ≤  1.10 
30/15  ratio* ≥ 1.04  1.01 – 1.03 ≤ 1.00 
IV atropine test** ≥ 1.21 1.11 – 1.20 ≤ 1.10 
'Decrease in systolic ≥ 10 mm of Hg 11-19 mm of Hg ≤ 20 mm of Hg 
pressure on standing*    
Increase in Diastolic    
Pressure   after ≥ 16 mm of Hg 11-15 mm of Hg ≤ 10 mm of Hg 
sustained  handgrip*    
'Reference - : * Ewing 53** Gulati54 
 
RESTING TACHYCARDIA 
Recorded by palpatory method and confirmed by ECG recordings. 
BODY MASS INDEX 
Body mass index BMI was calculated for each patient using the formula 
𝐵𝑀𝐼 =  
𝑊𝑒𝑖𝑔ℎ𝑡 𝑖𝑛 𝑘𝑔
𝐻𝑒𝑖𝑔ℎ𝑡 𝑖𝑛 𝑚2
 
. 
 
 
 
ULTRASONOGRAM ABDOMEN 
Ultrasonogram was performed to rule out renal calculus, enlargement of 
prostate and to measure the kidney size. 
Duration of diabetes, type of treatment and family history of diabetes were 
derived from the patient’s history and file. 
BIOCHEMICAL TESTS 
The following are the Biochemical tests carried out in this study. 
≠ Fasting Blood Sugar.  
≠ Post Prandial Blood Sugar 2 hr. after 75gm of Glucose load.  
≠ Blood Urea.  
≠ Serum Creatinine,  
≠ Serum Cholesterol.  
≠ Hemoglobin  
≠ 24 hrs Urinary Protien. 
Statistical association was calculated by using Chi-Square test. 
  
 ANALYSIS OF RESULTS 
 
 
 
General characteristics. 
This study was conducted on 40 diabetic patients including 4 newly detected 
diabetic patients- 65% were males and 35% were females. The age distribution of 
population studied ranged from 40 to 79 years. Their mean age was 55.37 ± SD 10.3 
years. The mean duration of diabetes was 5.00 ± SD 4.99 years. The mean fasting and 
post-prandial blood glucose level was 186 ± SD 55.45 mg% and 247 ± SD 54.87 
mg% respectively. The mean body mass index was 21.5 ± SD 4.2, the mean 24 hr 
urine protein was 372 mg and the mean cholesterol was 194.9 ± SD 35.2 mg%. 
10 healthy volunteers were studied as controls (6 males and 4 females). Their 
mean age was 51.5 ± SD 9.25 and BMI was 21.2 ± SD 2.3. The mean fasting and 
post-prandial blood sugar values were 83 ± SD 9.05 mg% and 98.4 ± SD 11.7 
mg%respectively. The mean 24 hr urine protein was 90.2 ± SD 3.9 mg. The mean 
cholesterol was 189 ± SD 11.93 mg%. No one in the control group had abnormal 
cardiovascular function tests. 
ANALYSIS OF SYMPTOMS 
The distribution of symptoms and signs of autonomic neuropathy and other 
characteristics are shown in table B.  
1. Postural hypotension 
Out of 40 diabetics studied 26 (65%) persons had  symptoms of postural 
hypotension. Out these 14 were males and 12 were females. The incidence of postural 
hypotension in males and females were 53.8% and 85.7% respectively (p<0.01). This 
suggests that in diabetics female sex is associated with greater incidence of postural 
hypotension. Out of 26 patients with postural hypotension only 9 (34.6*4) patients 
had systolic fall of blood pressure more than 20 mm of Hg upon standing and 11 
(42.6%) patients had borderline systolic blood pressure fall. This suggests that 6 
patients who had the symptom with normal systolic blood pressure fall upon standing 
may be due to other causes . 
The average age of diabetic patients with postural hypotension was 56 years 
and the average duration of diabetes was 5.46 years. The average fasting blood sugar 
value was 205 mg% and the average post prandial blood sugar value was 258 mg% 
suggesting that most of the people with this symptom had poor control of diabetes.  
2. Gastric fullness 
The total number of patients presented with this symptom were 30 (75%) 
among which 16 were males and 14 were females; out of 26 male diabetics studied 
only 16(<61.5%) had gastric fullness whereas all the 14 (100%) (p<0.01) females 
studied had this symptom. This suggests that association of gastric fullness is more 
common in females with diabetes than males. 
The average age of diabetics with this symptom was 55 years and the average 
duration was 5.53 years. All the patients had poor control of the disease with average 
fasting and post prandial blood sugar values 197 mg% and 252 mg % respectively.  
3. Nocturnal diarrhoea 
Nocturnal diarrohea was present in only 4 (10%) persons out of 40 diabetic 
subjects studied. The incidence of this symptom was 7.7% for males and 14.3% for 
females (p<0.01) suggesting that females with diabetic autonomic neuropathy have 
greater association with this symptom than males. 
The average age and duration of diabetes was 59 years and 5 years 
respectively. The average fasting blood sugar was 252 mg% and post prandial blood 
sugar value was 305mg%. The degree of control of diabetes was poor in all these 
patients. 
4. Urinary symptoms 
Urinary symptoms such as diminished sensation of bladder fullness, hesitation, 
weakness of stream and overflow incontinence were present in 10 (25%) patients with 
autonomic neuropathy of which 7 were males and 3 were females. The incidence of 
urinary symptoms in males and females was 26.9% and 21.4% (p). 
The average age of patients with urinary symptoms was 54 and the average duration 
was 7.5 years. The average fasting and post prandial blood sugar values are 201 mg% 
and 253 mg% respectively. This suggests that diabetics with longer duration of 
disease and poor control of their blood sugar level are likely to develop urinary 
symptoms.  
5. Impotence 
Out of 26 diabetic males studied 17 (65.4%.) of them had impotence. The 
average age of people with this symptom was 59 and the average duration was 3.56 
years and the average fasting blood sugar value was 195 mg%, the average post 
prandial blood sugar value was 259 mg%. Occurrence of impotence in males with 
diabetic autonomic neuropathy is not associated with duration of the disease whereas 
the association is greater with increasing age and poor degree of control. 
Out of 17 patients with impotence 11 (64.7%) had abnormal deep breathing 
test  9 (52.97%) had abnormal 30th/15th test and other parasympathetic function test 
were abnormal in less than 40%. Among the 17 patients with impotence, 3 (17.6%) 
had abnormal postural blood pressure test and 4 (23.5%) had abnormal handgrip test. 
 
 
6.Disturbance of sweating 
Overall 30 (75%) diabetic patients with autonomic neuropathy had sweating 
abnormality. Among these patients 18 (69.5%) were males and 12 (85.7%) were 
females. The average age and duration of diabetes was 53 years and 5.4 years 
respectively. The average fasting and post prandial blood sugar values were 194 and 
258 respectively. 
Out of 30 patients with abnormality of sweating 22 (73.3%) patients had 
abnormal deep breathing test and 19 (63.3%) had abnormal 30th/15th ratio test. Other 
test for parasympathetic function were abnormal in less than 50%. Among the patients 
with this symptom 8 (26.7%) had abnormal postural blood pressure test and 9 (30%) 
had abnormal handgrip test. 
It was observed that patients with longer duration of diabetes and poor degree of 
glycemic control are likely to have greater association with sweating abnormality. 
Both parasympathetic and sympathetic tests were found abnormal particularly the 
deep breathing test ,30th/15th test and handgrip test.  
7.Tingling and numbness 
Out of 40 subjects studied 32 (80%) had tingling and numbness, 20 (76.9%) 
patients were males and 12 (85.7%) patients were females. The average age and 
duration of diabetes was 50 years and 5.22 years respectively. The average fasting 
blood sugar was 198 mg% and post prandial blood sugar value was 261 mg%. Out of 
32 patients with this symptom 22 (68.5%) and 21 (65.6%) had abnormal deep 
breathing and 30th/15th ratio tests,53% had abnormal valsalva manoeuvre and 12.5% 
had abnormal atropine test. The postural blood pressure test and hand grip test were 
found to be abnormal in 9 (28.5%) and 11 (34.9%) respectively. 
The results suggest greater association of this symptom with increasing age 
and poor control. The cardiovascular function tests, more likely to be abnormal are 
deep breathing test , 30th/15th ratio test and handgrip test.  
8.Tendon reflexes 
All the patients studied were tested for presence or absence of both ankle and 
knee jerks. Ankle jerk was absent in 16 (40%) of patients. Among them 10 (38.5%) 
were males and 6 (42%) were females. Among the patients with absent ankle jerk the 
deep breathing test was abnormal in 75%, the 30th/15 test in 63.8%,the valsalva test 
in 50% and other tests including sympathetic function tests were abnormal in less than 
30% of patients. The knee jerk was abnormal in 5 (12.5%) patients with autonomic 
neuropathy; out of these 2 were males and 3 were females. 
 
In patient with absent knee jerk the average age and duration was 50 years and 
5.6 years respectively and the average fasting and post prandial blood sugar values 
were 188 mg% and 243 mg% respectively. Deep breathing test was abnormal in 60% 
and all other parasympathetic tests and handgrip test were abnormal in 40% patients. 
In patients with absent ankle jerk the average duration and age, fasting and post 
prandial blood sugar values were 6.38 years, 57years, 188 mg% and 247 
mg%respectively. Out of 16 patients, 12 (75%) had abnormal deep breathing test, 11 
(68.8%) had abnormal 30th/15th test. All other tests were abnormal in less than 26% 
of patients. 
Out of 21 patients with absent tendon reflexes 5 had both knee and ankle jerks 
absent. Right lateral popliteal motor nerve conduction velocity was delayed in 12 
patients out of 16 patients with absent ankle jerk and right median nerve motor nerve 
conduction velocity was delayed in 3 patients with absent knee jerk. The association 
of absent tendon reflexes is likely to be greater in patients with autonomic neuropathy 
with increasing age ,increasing duration of diabetes and with poorly controlled 
diabetes. 
9.Eye changes 
Out of 40 patients studied 4 (10%) had cataract and 3 (7.5%) had non 
proliferative diabetic retinopathy. The average duration of diabetes and age were 7 
years and 61years respectively. The average fasting and post prandial blood sugar 
values were 173 mg% and 231 mg%. Deep breathing test was abnormal in 71.4% of 
patients and 30th/15th ratio test was abnormal in 42% of patients. Valsalva test was 
abnormal in 47.1% of patients. The IV atropine test and handgrip test were abnormal 
in 14.3% of patients.   
Analysis of results showed that with increasing age and duration of diabetes 
and poor control there is greater association of development of retinopathy.  
10. Resting tachycardia 
Resting tachycardia was found in 13 (32.5%) patients out of 40 patients studied. The 
average age, duration, fasting and post prandial blood sugar values were 51 years, 6 
years, 195 mg% and 267 mg% respectively. 
 
92.5% of patients had abnormal deep breathing test, 84.6% of patients had 
abnormal 30th/15th ratio, 61.5% of patients had abnormal valsalva test and 7.7% of 
patients had abnormal atropine test. 
RESULTS OF CARDIOVASCULAR FUNCTION TESTS 
The results of cardiovascular tests are shown in the table C. 
 
 
1.Deep breathing test (El-Ratio) 
In this study El-Ratio was used to assess the parasympathetic dysfunction. Out 
of 40 subjects with diabetes of varying duration and age studied, the test was 
abnormal in 27 (67.5%)  patients, borderline in 11 (27.5%) patients and normal in 2 
(5%) patients, the distribution of abnormality was approximately same in males and 
females. The average age, duration, fasting and post prandial blood sugar values for 
patients  with  abnormal  test were 54 years, 5.4 years, 197 mg%, 257 mg% 
respectively. 
It was observed from this study that patients with abnormal deep breathing test 
had longer mean duration of the disease and higher mean fasting and post prandial 
blood sugar values when compared to patients with normal test. Age doesn't correlate 
with positive test result. 
 
2. Heart rate response to getting up from lying to standing (30th/15th ratio)  
This test is used to assess parasympathetic abnormality. A total of 23 (57.5%) 
patients found to have abnormal 30th/15th ratio test. In 17 (42.5%) patients the test 
was found to be normal. Out of 23 patients with abnormal test 13 (50%) were males 
and 10 (71.4%) were females. In the normal group there were 17 patients. 13 (50%) 
were males and 4 (28.6) were females. In patients with abnormal test the average age 
was 54 years and the average duration of diabetes was 5.1 years. The average fasting 
and post prandial blood sugar values were 201 mg% and 265 mg% respectively, 
whereas in patients with normal test the average age ,duration, fasting and post 
prandial blood sugar values were 59 years,4.8 years,166 mg%,223 mg% respectively. 
 
 
The results of this test shows that in diabetes with autonomic neuropathy 
females are more likely to have positive 30th/15th ratio test and there is a greater 
association of positive test with increasing age, duration and degree of metabolic 
control.  
 
Deep breathing test: ECG recordings showing R-R intervals during inspiration 
and expiration in (A) normal person. (B) Diabetic patient with autonomic 
neuropathy.  
  3. Valsalva manoeuvre 
Overall 18 (45%) patients had abnormal valsalva test,15 (37.5%) patients had 
borderline test and 7 (17.5%) had normal test results. The sex distribution of abnormal test 
was more or less same. The average age, duration, fasting and post prandial values for the 
abnormal group were 54 years,7.1 years, 205 mg% and 259 mg% respectively and for the 
normal group the values were 55 years,2.9 years,167mg%,231 mg% respectively.  
Valsalva manoeuvre: ECG recordings showing R-R intervals during and immediately 
after the procedure in (A) Normal person. (B) Diabetic patient with autonomic neuropathy.  
It is observed that increasing duration and poor degree of control of diabetes have 
positive correlation with abnormal test result. Age does not correlate with abnormality.  
 
4. IV Atropine test 
Only 5 (12.5%) out of 40 patients were found to have abnormal atropine test. 
55% of test population had normal test response to atropine and 37% had borderline 
test response.61.5% of males and 42.3% of females had normal response,30.8% of 
males and 35.7% of females had borderline response to atropine and 7.7% of males 
and 21.4% of females had abnormal test response respectively. The average age, 
duration, fasting and post prandial sugar values for the abnormal group were 50 
years,4.6 years,245 mg% and 301 mg% respectively. In the normal group the average 
age, duration and fasting and post prandial sugar values were 55 years, 3.9 years,166 
mg% and 235 mg% respectively. In this test also there exist positive correlation with 
poor degree of control of diabetes and duration when compared to normals. Age does 
not show any positive correlation with abnormality of the test.  
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5.Postural blood pressure test 
Analysis of postural blood pressure test results showed incidence of abnormal 
test was 25% and the male to female distribution was 19.2% and 35.7% respectively. 
Out of 40 test population 35% had borderline response to standing from lying, among 
these 30.8% were males and 42.9% were females. 40% of patients fall under normal 
group .In normal test group the male to female distribution were 50% and 21.4% 
respectively. The average age, duration of diabetes, fasting and post prandial blood 
sugar values in patients with abnormal test were 60 years,6.8 years,209 mg% and 259 
mg% respectively and in normal test group were 55 years,4.1 years,172 mg% and 240 
mg% respectively. 
 
In this study it was observed that increasing age, duration of diabetes and poor 
degree of control have strong influence on postural blood pressure test. This test was 
abnormal in only 9 patients out of26 patients with symptom of postural hypotension. 
6. Sustained handgrip test 
Out of 40 patients studied 30% were found to have abnormal increase in 
diastolic blood pressure more than 16 mm of Hg. of which male to female distribution 
was 23.1% and 42.9% respectively.62.5% of test population had normal increase in 
diastolic blood pressure of which 73.1% were males and 42.9% females. 7.5% fall 
under borderline group among them 3.8% were males and 14.3% were females. The 
average age, duration, fasting and post prandial blood sugar values in normal test 
population were 56 years,3.4years,168 mg% and 234 mg% respectively and the 
average values in abnormal test population was 54 years, 8.5 years, 218mg% and 276 
mg% respectively.  
This test is used to assess sympathetic function. Those patients with abnormal 
test were considered to have sympathetic damage. Poor degree of control of the 
disease and longer duration disease have greater association with abnormality of this 
test.  
7. Squatting test 
 Both sympathetic and parasympathetic dysfunction may be assessed with this 
single test. In this study all the 40 subjects studies were found to have abnormal Sq T 
– Vagal ratio and 37 out of 40 patients had abnormal Sq T – Sympathetic ratio and 3 
had normal sqt -sympathetic ratio 
 
 
 
 
 
 
 
 
 
 
 
 
 
valsalva manoeuvre  
  
IV ATROPINE TEST  
SQUATTING TEST  
ANALYSIS OF GRADING OF DYSAUTONOMIA  
Grading of severity of autonomic neuropathy was done according to lakotia et al, 
1997.55  
Grading of dysautonomia according to Lakotia et al 199755 
Grade Severity Result  of 
parasympathetic tests 
Result of 
sympathetic tests 
0 Normal sympathetic and 
parasympathetic functions 
All normal or  one 
Borderline 
Normal 
I Mild parasympathetic 
dysautonomia  
One abnormal or two   
borderline 
Normal 
II Moderate parasympathetic 
dysautonomia 
Two abnormal or one 
abnormal and two 
borderline 
Normal 
III Severe parasympathetic 
dysautonomia 
More than two 
abnormal results 
Normal 
IV Combined parasym- pathetic 
and sympathetic 
dysautonomia 
Any parasympathetic 
abnormality 
One abnormal or 
two borderline 
 
Distribution of grades of dysautonomia in the study population and its relations 
to age, duration of the disease, metabolic control, symptoms and signs, body mas 
index, proteinuria, serum cholesterol and type of treatment are shown in tables. 
 
 
 
DISTRIBUTION OF VARIOUS GRADES IN THE POPULATION STUDIED.  
Table D 
 
 
This above bar  diagram shows increased incidence of grade 4 dysautonomia in both 
male and female diabetic population.    
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Bar diagram showing male and female 
distribution with respect to grading of 
dysautonomia
male
female
TOTAL
Grade Male Female Total Fasting Blood 
Sugar 
Post. Prandial 
Blood Sugar 
0 
4 
(10%) 
0 
4 
(10%) 
158 225 
I 2 (7.7%) 
3 
(21.4%) 
5 
(12.5%) 
166 229 
II 
10 
(38.5%) 
3 
(21.4%) 
13 
(32.5%) 
172 238 
III 
2 
(7.7%) 
1 
(7.1%) 
3 
(7.5%) 
193 257 
IV 
8 
(30.8%) 
7 
(35%) 
15 
(37.5%) 
211 264 
DISTRIBUTION OF AGE IN RELATION TO DYSAUTONOMIA  
Table E 
Age Group Total No Grade 
0 
Grade 
I 
Grade 
II 
Grade 
III 
Grade 
IV 
40 - 50 16  (40%) - 3  (8.8%) 4  (25%) 2(12.5%) 7(43.5%) 
51 - 60 14  (35%) 2(14.3%) - 5(35.7%) 1 (7.1%) 6(42.9%) 
61 - 70 6   (15%) 2(33.3%) 1 (16.7%) 2 (33.3%) - 1(16.7%) 
71 - 80 4   (10%) _ 1  (25%) 2  (50%) - 1 (25%) 
Total 40 (100%) 4 (10%) 5 (12.5%) 13(32.5% 3 (7.5%) 15 (75%) 
 
 
 
This table shows the distribution of age in the study group  in relation to the grades of 
dysautonomia . 
 
 
 
 
 
 
 
 
 
 
 
GRADING OF DYSAUTONOMIA AND ITS RELATION TO DURATION OF 
DIABETES. DURATION IN YEARS AND TOTAL NOS. IN EACH GRADE 
AND PERCENTAGE 
Table F 
         
 Duration Total No Grade 0 Grade I Grade II Grade III Grade IV 
 
 
< 1 year 6  (15%) _ 2(33.3%) - 1 16.7%) 3  (50%)  
1 – 5 20 (50%) 3 (15%) 2  (10%) 11 (55%) 2 (10%) 2  (10%)  
 6-10 8  (20%) 1(12.5%) - 1(12.5%) - 6  (75%)  
 11 – 15 4  (10%) - - 1  (25%) - 3  (75%)  
>15 years 2  (5%) - 1  (50%) - - 1  (50%)  
Total 40 (100%) 4 (10%) 5(12.5%) 13(32.5% 3 (7.5%) 15 (75.5%  
 
   
 
 
       
 
 
This above chart shows increase in incidence of grade  4 dysautonomia in the 
population with greater than 10years of duration of diabetes mellitus .  
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Grade 0
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>15years
GRADING OF DYSAUTONOMIA AND ITS RELATION TO DEGREE OF 
CONTROL ACCORDING TO FASTING BLOOD SUGAR LEVEL. TOTAL 
NOS. IN EACH GROUP AND THE PERCENTAGE.   p value<0.01% 
 
Table G. 
       
Degree of 
Control 
Total No Grade 
0 
Grade 
I 
Grade 
I I 
Grade 
I I I 
Grade 
IV 
Good 7 (17.5%) 2(5 %) 1(2.5%) 1 (2.5%) 1 (2.5%) 2( 5 %) 
Fair 8 (20%) - 1 (2.5%) 7(17.5% - - 
Poor 25(62.5%) 2(5 %) 3(7.5%) 5(12.5% 2(5 %) 13(32.5% 
Total 40 (100%) 4 (10%) 5(12.5%) 13(32.5% 3 (7.5%) 15(35.5% 
 
 
This chart shows increased prevalence of grade 4 dysautonomia  in the population 
with poorer glycemic control . 
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DISTRIBUTION OF NUMBER OF PATIENTS IN EACH GRADE 
ACCORDING TO AUTONOMIC SYMPTOMS. 
Table H. 
Sympto
m 
Total 
Nos. 
Grade 
0 
Grade 
I 
Grade 
II 
Grade 
III 
Grade 
IV 
Postu. 
Hypot. 
26 
(65 %) 
2 3 5 3 13 
Gast. 
Fulnes 
28 
(70 %) 
2 4 8 2 12 
Noct. 
Diarr. 
4 
(10 %) 
0 1 0 0 3 
Urina. 
Symp. 
10 
(25 %) 
1 1 3 0 5 
Sweat. 
Abnor. 
25 
(62.5% 
1 3 7 1 13 
Impot. 14 
(35%) 
2 0 7 0 5 
Ting1. 
Numbn . 
28 
(70 %) 
1 3 7 3 14 
Knee 
Jerk 
5 
(12.5% 
0 1 2 0 2 
Ankle 
Jerk 
16 
(40 %) 
0 1 8 1 6 
Eye.Ch 
Catrac 
4 
( 10 % ) 
0 1 3 0 0 
Eye.ch 
NPDR 
3 
(7.5%) 
0 0 1 0 2 
Restig 
Tachyc 
13 
(32.5% 
0 0 7 1 5 
 
 This above bar chart shows that there is increased prevalence of postural hypotension 
, gastric fullness , sweating abnormalities , paresthesias , resting tachycardia in the 
study group with grade 4 dysautonomia . 
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DISTRIBUTION OF GRADES OF DYSAUTONOMIA IN RELATION TO 
BODY MASS INDEX 
 
Table J.         P > 0.05 
 
Grade Over Wt .& 
Obese 
Nos.  % 
Non Obese 
Nos.     % 
0 1 25 3 75 
I 3 60 o 40 
II 1 7.7 12 92.3 
III 0 0 3 100 
IV 4 26.7 11 73.3 
 
 
 
There was no statistically significant relation between the body mass index and 
dysautonomia . 
 
 
 
 
DISTRIBUTION OF GRADES OF DYSAUTONOMIA ACCORDING TO 
PROTEINURIA 
Table K.        P<0.01 
       
 Grade 24 Hr Protein 
>150mg 
Nos.      % 
24 hr Protein 
<150mg 
Nos.    % 
 
 0 3 75 1 14.2  
 I 3 60 2 28.4  
 II 12 92.3 1 7.7  
 III 10 100 0 0  
 IV 12 80 3 20  
 
 
 
This above chart shows that there is >150mg protein in urine /day in the study 
population with grade 2 and more than 2 dysautonomia 
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DISTRIBUTION OF GRADES OF DYSAUTONOMIA ACCORDING TO 
SERUM CHOLESTEROL 
Table L.       p>0.05 
     
Grade 
Cholesterol ≥200mg   
Nos.          % 
Choleterol < 200mg      
Nos.       % 
0 1 25  3 75 
I 2 40  3 60 
II 3   
23.1 
 
23.1 
10 76.9 
III 0 0  3 100 
IV 6 40  9 60 
      
 
There was no stastically significant correlation between levels of cholestrrol and 
grades of dysautonomia in this study . 
 
 
 
 
 
 
 
 
 
 
DISTRIBUTION OF GRADES OF DYSAUTONOMIA ACCORDING TO 
TYPE OF TREATMENT. 
Table M         P > 0.05. 
Grade OHA Alone   Nos.    
% 
OHA And Insulin 
Nos.     % 
Not on treatment    Nos.        
% 
 0 4 100 0 0 0 0 
I 1 20 2 40 2 40 
II 12 92.3 1 7.7 0 0 
III 2 66.7 0 0 1 33.3 
IV 11 73.3 3 20 1 6.7 
 
 
There was no stastically significant correlation between the type of treatment and 
grades of dysautonomia in this study . 
 
 
 
 
 
 
 
 
 
 
RESULTS OF CARDIOVASCULAR FUNCTION TESTS IN TYPE 2DM  
 
GROUP 
TEST RESULT 
DEEP 
BREATHING 
TEST (n) % 
30/15 
RATIO(n)% 
ATROPINE(n) 
% 
PBT(n) % HGT % 
Valsalva 
Mano 
euvre  
WHOLE 
GROUP 
NORMAL (2)5% (17)42.50% (22)55% (16)40% 
(25)62.50
% 
7 
(17.5%) 
BORDERLINE (11)27.50% (0)0% (13)32% (14)35% (3)7.50% 
15 
(37.5%) 
ABNORMAL (27)67.50% (23)57.50% (5)12.50% (10)25% (12)30% 
18 
(45%) 
MALES 
NORMAL (2)7.60% (13)50% (16)61.50% (13)50% 
(19)73.10
% 
4 
(15.4%) 
BORDERLINE (7)26.90% (0)0% (8)30.80% (8)30.80% (1)3.80% 
11 
(42.3%) 
ABNORMAL (17)65.40% (13)50% (2)7.70% (5)19.20% 
(6)23.10
% 
11 
(42.3%) 
FEMALES 
NORMAL (0)0% (4)28.60% (6)42.90% (3)21.40% 
(6)42.90
% 
3 
(21.4%) 
BORDERLINE (4)28.60% (0)0% (5)35.70% (6)42.90% 
(2)24.30
% 
4 
(28.6%) 
ABNORMAL (10)71.40% (10)71% (3)21.40% (5)35.70% 
(6)42.90
% 
7 
(50%) 
 
This table shows that deep breathing test yielded more abnormal results in suggesting 
autonomic dysfunction. 
 
  
this illustration shows that tests such as deep breathing tests are more yielding in 
detecting autonomic dysfunction. 
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 DISCUSSION 
This study was conducted on 40 Type2 diabetic patients- 65% of them were 
males and 35% females. The mean age of the population studied was 55.4 ± 10-3 
years, and the mean duration of diabetes was 5.2 ± 5 years- The mean fasting and 
postprandial plasma glucose was 186 ± 55.45 mg% and 247 ± 54-87 mg% 
respectively. The majority of patients (40%) studied were in the age group of 40 - 60 
years, (35 %) in the age group of 51-60 years, (15 %) of patients were in the age 
group of 61-70 years and (10 %) were in the age group of 71-80 years. The age of the 
population studied ranged from 40 to 79 years. 
The duration of diabetes in most of the patients (50%) were in the group 1-5 
years, 20 % of the patients were in 6 - 10 years group,10 % patients were in the 11 - 
15 years group, 15 %of patients were in the <1 year group and only 2 (5 %) patients 
in the >15 years group. The disease duration in the population studied ranges from <1 
years to 20 years. 
Bulk of patitents (75 %) studied were on oral hypoglycemic drugs,15 % of 
patients were taking Insulin along with oral hypoglycemic agents and 10 % of patients 
who were newly detected as Type2 DM were not on any drugs. 50 % of the patients 
were on regular treatment and the rest were irregular in taking drugs. Most of the 
patients (62 %) were under poor degree of control of the disease with mean fasting 
and postprandial blood sugar value 219 ± 42.8  mg  % and 272.88 ± 49.22 mg%, 20 % 
of the population studied were under fair control with  mean fasting and postprandial 
blood glucose values 143 ± 6.12 mg% and 220 ± 33.23 mg% respectively. Only 
17.5% were under good control with mean fasting and postprandial blood glucose 
values 117.7 ± 10.48 mg% and 185 ± 19.56 mg% respectively.  
Autonomic involvement in diabetes mellitus has been widely studied earlier 
utilising non-invasive and invasive tests. It has been advocated that a battery of tests 
are better in detecting the autonomic involvement than single test done (*123,lakotia). 
In this study a battery of  six  
autonomic function tests were performed to assess the integrity of both sympathetic 
and parasympathetic function. 
It has been found in this study that 33 (82.5%) of patients studied had one or 
more autonomic symptoms suggestive of autonomic neuropathy and 7 (17.5%) of 
population did not have any symptoms of autonomic impairment. Out of 33 patients 4 
were established to have grade I dysautonomia,9  patients with grade II 
dysautonomia,3 with grade III dysautonomia and 15 were found to have grade IV 
autonomic neuropathy. Two patients were found to have normal autonomic function. 
In the symptomatic group 13 patients were found to have grade II autonomic damage 
and one was found with grade I dysautonomia. Two patients were found to have 
normal autonomic function and none of the patients were in grade III or IV group. 
Among the seven asymptomatic patients, five had evidence of dysautonomia on 
testing. 
The presence of common symptoms such as impotence, postural dizziness and 
gustatory sweating 3,47 which are commonly seen in diabetes do not essentially mean 
damage to the autonomic nervous system. In this study out of 26 patient who 
complained of postural dizziness only 34.6% had abnormal fall in systolic blood 
pressure 20 mm of Hg. The complaint of postural dizziness may be due to other 
causes.  
According to Ewing DJ. Et all (1930)3 the presence of diabetic diarrhea almost 
always indicates severe autonomic damage. In our study four patients had diabetic 
diarrhoes and all of them were found to have severe autonomic dysfunction (grade 
IV). Out of 40 diabetic subjects 10 (25%) patients complained of symptoms 
suggestive of involvement of bladder, of which 9 (90%) had abnormal 
parasympathetic function tests and 5 had abnormal sympathetic tests. This is in 
agreement with frimodt et all (1980) 56 who described that infrequently seen 
symptoms like dysphagia or abnormal bladder are also indicative of widespread 
autonomic damage.  
A study of the various tests of autonomic functions showed that 82% patients had 
parasympathetic system involvement where as only 37.5% had sympathetic 
involvement in the subjects studied. This observation is in agreement with that of 
Ewing DJ. et.al al29 and Banister R.57who suggested that sympathetic involvement in 
the course of diabetic autonomic neuropathy occurs later  than parasympathetic 
involvement.  
Among the individual tests of parasympathetic function, the greatest proportion 
of abnormal responses was seen in the deep breathing test (Beat to beat variation in 
the heart rate) in 27 patients (75 %). This is followed by the lying to standing test 
(30th/15th Ratio) in 23 patients (63.8 %),  and finally the atropine test 5 patients (13.8 
%).Among the sympathetic tests the incidence of abnormality was 27.7 % with 
sustained hand grip test and 33.3 % with postural blood pressure test. This suggests 
that in clinical practice the deep breathing test and the hand grip test may be the most 
easily observable and reproducible tests to evaluate the abnormalities of 
parasympathetic and sympathetic function  respectively. 
The novel squatting test described by marfella et al38 combines both 
sympathetic and parasympathetic assessment in diabetic autonomic neuropathy in a 
single procedure. In our series 100 % patients had abnormal 
47 
parasympathetic component of the squatting test. It is relevant to note that even 
among 4 patients who had normal autonomic function according to the criteria of 
Lakotia et al the responses to squatting test was abnormal. It has been suggested by 
Marfella et al38 that the squatting test may be the earliest indicator of diabetic 
autonomic neuropathy. All patients tested in our study had an abnormal squatting test 
response, even among those who had no other evidence of diabetic autonomic 
neuropathy. 
In this study the severity of autonomic impairment was categorized as Grade 0 
(Normal) - Grade IV (Severe) according to the criteria proposed by Lakotia et al 
(1997).55 
According to this classification 90 % of patients out of a total of 40 were found 
to have autonomic impairment ranging from grade I to grade IV. Studies which were 
done earlier  reported dysautonomia in 20- 60 % of patients. Either a single test or a 
minimum number of tests were considered in defining autonomic neuropathy in all 
the series. The high incidence of autonomic neuropathy in this study may be attributed 
to increased number of tests the patients were subjected to, small number of study 
population and majority of patients studied were under poor degree of metabolic 
control. 
The frequency of male and female distribution of autonomic dysfunction was 
55% and 35% respectively. Out of 26 male patients studied 22.84% had autonomic 
dysfunction and all the female patients studied were found to have autonomic 
neuropathy. There was a highly significant sex difference in the distribution of classes 
of dysautonomia (p<0.001). This difference is mainly due to excess of female patients 
50% in grade IV degree in this study. This may also be due to small number of 
females 35% when compared to 65% of males included in this study. However, this 
finding is in accord with Veglio et al, who documented a significant sex difference in 
distribution of class in his study group comprising 221 Type2 diabetic patients (108 
males and 113 females). 
In this study it has been found that no significant correlation was found 
between severity of autonomic neuropathy and age. Majority of patients (43.76%) 
with grade IV autonomic neuropathy were found to be in the age group of 40 to 50 
years. No significant correlation was found between duration of diabetes and severity 
of autonomic dysfunction in this study- 95% of patients with grade IV dysautonomia 
were found in the 6 to 10 years duration, which comprises a total of 8 patients and 4 
patients( that is <75%) in the 11 to 15 years duration group. 55% of patients with 
grade II dysautonomia were in the duration group 1 to 5 years. Only two patients had 
the disease duration  more than 15 years. One with 16 years of diabetes and the other 
with 20 years of diabetes. The patient with 20 years of disease duration was found to 
have grade IV autonomic impairment with all the tests abnormal except atropine test. 
Her fasting and postprandial blood sugar values were 172 mg% and 202 mg% 
respectively. The other patient with disease duration of 16 years was with grade I 
dysautonomia was found to have only deep breathing test abnormal. His fasting and 
postprandial blood sugar values were 104 mg% and 168 mg%. This suggests that the 
degree of metabolic control is an important factor that decides severity of autonomic 
impairment rather than the duration of diabetes. 
Of the 6 (15%) patients with disease duration less than  one  year  which  
include 4 newly detected diabetic patients 3 were found to have grade IV autonomic 
neuropathy, one patient grade III and two grade II dysautonomy. This may be 
attributed to insidious onset and asymptomatic nature of the disease and to difficulty 
in determining the exact onset of the disease in Type 2 diabetic patients. It is evident 
from this study that there is a gradual increase in the severity of autonomic 
impairment with worsening degree of metabolic control, with increase in mean fasting 
and post prandial blood glucose values from 158mg% and 225 mg% for grade 0 
(normal) to 210 mg% and 264 mg% respectively for patients with grade IV 
dysautonomia. 
Among all the variables studied the degree of metabolic control was found to 
have strongest correlation with the extent of diabetic autonomic neuropathy (p<0.01). 
Patients in the poor control group (Mean fasting blood glucose 219 ± SD 42.8 mg% 
and postprandial blood glucose 272 ± SD 49.2 mg%) tend to have greater incidence of 
autonomic symptoms. They also showed greater proportion of patients with grade IV 
diabetic autonomic neuropathy compared with good control (52 % vs 28 % <p<0.05). 
This is in accordance with  the results of the Diabetes Control and Complication Trial 
(DCCT)58 which emphasise the need to maintain near normal glycemic state in order 
to prevent the progression of late complications of diabetes mellitus. 
Patients with Type 2 Diabetes Mellitus are treated with varying combinations 
of oral hypoglycemic agents and insulin by different physicians. A variety of  reports 
appear periodically claiming  relative advantage of a single regimen over the other in 
preventing long term  complications of diabetes. However, the results of this study did 
not show any correlation between the type of treatment regimen (whether OHA/ OHA 
& INSULIN) and the degree of autonomic impairment. This lack of effect was seen to 
persist even in comparison between patients undergoing regular or irregular treatment. 
An interesting observation in this study has been that 50 % of patients were on 
"Regular" treatment had poor metabolic control (Mean fasting and post - prandi al 
blood sugar values 219 ± SD 42.8 mg % and 272 ± SD 49.2 mg %) respectively. 
This also reinforces the fact that the quality of glycemic control is the most 
important factor rather than the type of treatment or regularity in the prevention or 
progression of diabetic autonomic neuropathy. 
Results of this study showed that 60 % of patients had grade I autonomic 
neuropathy and 26.7%had grade IV dysautonomia in over weight and obese group 
<Body mass index  24.9.) In the non obese group 40 % of patients were found to be 
with grade 1 and 73.3 % with grade IV autonomic impairment.  
This suggests that there exists no correlation between body mass index and 
severity of autonomic neuropathy.(p>0.05). 
It has been found in this study 15 patients had grade IV autonomic impairment 
out  of which 80 % were in the proteinuric group (24 hour urine protein 150 mg) and 
only 20 % were in the non proteinuric group (24 hour urine protein 150mg ). This is 
statistically signifigant (p<0.01) suggesting that there exist a significant correlation 
between increased protein excretion and severity of autonomic damage. Result of this 
study showed out of 15  patients with grade IV dysautonomia 40% were in the group 
of serum cholesterol > 200 mg% and 60 %  in the group of serum cholesterol <200 
mg%, suggesting that no significant correlation exist between hypercholesterolemia 
and severity of autonomic neuropathy. 
 
 
 
 
 
 
 
 CONCLUSIONS 
1. 90% of patients studied  had  prevalence of diabetic autonomic neuropathy.  
2. Parasympathetic involvement was seen in 82.5% of patients while sympathetic 
involvement was seen in 37.5% 
3. Parasympathetic involvement generally occurs earlier than sympathetic 
involvement.  
4. Evidence of prevalence of autonomic dysfunction may be discovered even in 
asymptomatic patients by applying the tests described in the study.  
5. Nocturnal diarrhoea and urinary symptoms had the greatest correlation with the 
severity of autonomic impairment.  
6. Among the tests performed, the heart rate response to deep breathing and to 
postural change from lying to standing were found to be the most sensitive in 
detecting prevalence of  autonomic neuropathy. 
7. The squatting test may be used as an early marker of prevalence of subtle 
autonomic impairment, even in asymptomatic diabetics. 
8. A battery of tests is more accurate in assessing the degree of involvement of 
the autonomic system rather than a single test. 
9. No correlation was found between the severity of dysautonomia and age, sex, 
body mass index or duration of diabetes. 
10. There was an increased incidence of proteinuria in those with advanced 
autonomic neuropathy. 
11. Hypercholesterolemia did not affect the severity of dysautonomia significantly 
in diabetic patients.  
12. The type of treatment given did not correlate significantly with severity of 
autonomic damage in this study. 
13. Most patients with advanced grades of autonomic impairment also had 
evidence of peripheral neuropathy in the form of delayed motor nerve 
conduction velocity as assessed by means of electrophysiological testing.  
14. Among all the variables included in this study, the degree of metabolic control 
was found to have the strongest correlation with prevalence of diabetic 
autonomic neuropathy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 SUMMARY 
This study revealed a high prevalence of autonomic neuropathy in Type2 
Diabetes mellitus patients. This was also evident even in asymptomatic patients. The 
squatting test can be used as an early marker of dysautonomia. The degree of 
metabolic control was the factor which had the strongest association with severity of 
autonomic impairment. Thus, this study underscores the value of tight metabolic 
control in the ideal management of Type2 Diabetes mellitus. 
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to participate in the study conducted by DR. IVAN A JONES,  Post graduate 
in 
the Department of General Medicine, Thanjavur Medical College & Hospital, 
Thanjavur – 613004 and to use my personal clinical data and result of 
investigation for the purpose of analysis and to study the nature of disease. I 
also give consent for further investigations.  
 
 
Place : 
Date : 
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PROFORMA 
Name :      Age :   Sex : 
Occupation :     IPNO :   DOA : 
Duration of Diabetes: 
Treatment : DIET/OHA/OHA & INSULIN / INSULIN / NONE  
     REGULAR / IRREGULAR 
HEIGHT :  Cms WEIGHT :   BMI :  F/H : YES/NO 
SYMPTOMS AND SIGNS 
POSTURAL HYPOTESION   IMPOTENCE 
DYSPHAGIA     DISTURABANCE OF SWEATING 
VOMITING     INCREASED GUSTATORY SWEATING 
GASTRIC FULNESS    TINGLING AND NUMBNESS 
NOCTURNAL DIARRHOEA  ASSENT KNEE JERK 
CONSTIPATION    ASSENT ANKLE JERK 
STRAINING AND HESITATION  PUPILARY CHANGES 
WEAKNESS OF STREAM   OTHERS 
SENSATION OF INCOMPLETE EMPTYING 
DECREASED FREQUENCY OF MICTURATION 
OVER FLOW INCONTINENCE 
RESTING HEART RATE : 
BEAT TO BEAT HEART RATE VARATION : 
DEEP INSPIRIATION  :  (Min R-R Nit) :    msec 
DEEP EXPIRATION :  (Max R-R Int) :    msec 
HEART RATE RESP ONSE TO STANDING : 
LYING ( R-R Int) :   msec  STANDING : 15th BEAT (R-R Int)  :  msec 
     30th BEAT (R-R Int)    :  msec 
30th / 15th RATIO : 
SQUATTING TEST 
PHASE 1 : msec 
PHASE 2: msec 
PHASE 3 : msec 
SqTv RATIO   : 
SqTs RATIO   : 
BP RESPONSE ON STANDING 
SUPINE BP    : mm Hg  STANDING BP :    mm Hg 
SYSTOLIC BP FALL  : mm Hg 
HAND GRIP TEST 
BP BEFORE TEST       :     mmHg   BP DURING TEST :    mmHg 
DIASTOLIC BP RISE  :     mm Hg 
HR CHANGES TO Inj ATROPINE 
BEFORE InJ (R-RInt)       : msec   RATIO ; 
AFTER Inj (R-RInt)         : msec 
BIO CHEMICAL DATA: 
BLOOD SUGAR: FASTING  : mg%                  Hb :         gms% 
BLOOD SUGAR   PP : mg% 
BLOOD UREA   : mg% 
SERUM CREATININE      : mg% 
SERUM CHOLESTEROL       : mg% 
24 Hr. URINE PROTEIN  : 
ULTRA SONOGRAM ABDOMEN : 
  
 KEY TO MASTER CHART 
 
ATROPINE TEST: 
At__bf−R−R interval in msec          At_af—R-R interval in msec 
before atropine    after atropine 
At_ra-Atropine test ratio            Ar - Atropine test result 
Sbl, Dbl-Systolic, diastolic BP        Sbs, Dbs-Systolic, diastolic BP 
lying         standing 
Sbf-Systolic BP fall      Pr-Postural fall result 
 
HANDGRIP TEST: 
HI, H2-Systolic,diastolic BP          H3,H4-Systolic,diasto1ic BP 
before handgrip      after handgrip 
Rd-Diastolic BP rise      Hr-Handgrip test result 
Pa, Pb, Pn-Parasympathetic tests: abnormal, borderline, normal 
Sa, Sb, Sn- Sympathetic tests: abnormal, borderline, normal 
GRD-Grading 
Cvp, Cvm-Conduction velocity: Pop 1iteal,Median 
Rp, Rm-Results: pop 1iteal,median 
Fbs, Pbs-Fasting, postprandial blood sugar 
Cho-Cholesterol      Urp-24 hours urine protein 
Bu-Blood urea      Sc-Serum Creatinine 
Hb-Hemoglobin      Usg-Ultrasonogram 
0 - Oral hypoglycemic agents         0&I - Oha & Insulin, 
 
SYMPTOMS AND SIGNS: 
P - Present: A - Absent 
 
TEST RESULTS: 
N - Normal: B - Borderline : A - Abnormal D - Delayed 
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